<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0//FR" "http://www.w3.org/TR/REC-html40/strict.dtd">
<!-- template_7 -->
<HTML>
  <HEAD>
    <META http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
    <META name="organization" content="ANSM : Agence Nationale de Sécurité du Médicament et des Produit de santé">
    <META name="description" content="Résumé des Caractéristiques du Produit">
    <META name="keywords" content="RALOXIFENE CRISTERS 60 mg, comprimé pelliculé, Médicament, Spécialité pharmaceutique, RCP, Résumé des Caractéristiques du Produit, Dénomination, Forme pharmaceutique, Indications, Contre-indications, Effets secondaires">
    <TITLE>Résumé des Caractéristiques du Produit</TITLE>
    <link rel="stylesheet" href="../style/spstyl01.css" type="text/css">
  </HEAD>
  <BODY>
<p class="AmmAnnexeTitre"><a name="RcpTitre">RÉSUMÉ DES CARACTÉRISTIQUES DU PRODUIT</a></p>
<p class="DateNotif">ANSM - Mis à jour le : 29/12/2014</p>
<p class="AmmAnnexeTitre1"><a name="RcpDenomination">1. DENOMINATION DU MEDICAMENT</a></p>
<p class=AmmDenomination>RALOXIFENE CRISTERS 60 mg, comprimé pelliculé</p>
<p class="AmmAnnexeTitre1"><a name="RcpCompoQualitQuanti">2. COMPOSITION QUALITATIVE ET QUANTITATIVE</a></p>
<p class=AmmComposition>Chlorhydrate de Raloxifène................................................................................................................ 60,0 mg</p>
<p class=AmmComposition>Equivalent à Raloxifène base............................................................................................................. 56,0 mg</p>
<p class=AmmComposition align=center style='text-align:center'>Pour un comprimé pelliculé</p>
<p class=AmmCorpsTexte><u>Excipient</u> :</p>
<p class=AmmCorpsTexte>Chaque comprimé pelliculé contient 1,5 mg de lactose monohydraté.</p>
<p class=AmmCorpsTexte>Pour la liste complète des excipients, voir rubrique 6.1</p>
<p class="AmmAnnexeTitre1"><a name="RcpFormePharm">3. FORME PHARMACEUTIQUE</a></p>
<p class=AmmCorpsTexte>Comprimé pelliculé. </p>
<p class=AmmCorpsTexte><span class=hps>Comprimé blanc, pelliculé, de forme elliptique.</span></p>
<p class="AmmAnnexeTitre1"><a name="RcpDonneesCliniques">4. DONNEES CLINIQUES</a></p>
<p class="AmmAnnexeTitre2"><a name="RcpIndicTherap">4.1. Indications thérapeutiques</a></p>
<p class=AmmCorpsTexte>Le chlorhydrate de raloxifène<span style='letter-spacing: .05pt'> </span>est<span style='letter-spacing:.05pt'> i</span>ndiqué dans <span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> tr</span>a<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>pré<span style='letter-spacing:-.1pt'>v</span>en<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:-.05pt'> </span><span style='letter-spacing:.05pt'>l’</span>os<span style='letter-spacing:.05pt'>t</span>éoporose<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing: .05pt'>l</span>es<span style='letter-spacing:.05pt'> f</span>e<span style='letter-spacing:-.2pt'>mm</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>énop<span style='letter-spacing:-.05pt'>a</span>usées. <span style='letter-spacing:-.05pt'>U</span>ne <span style='letter-spacing: .05pt'>r</span>éduc<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>s<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>g</span>n<span style='letter-spacing:.05pt'>ifi</span>ca<span style='letter-spacing:.05pt'>ti</span><span style='letter-spacing:-.1pt'>v</span>e<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>l’i</span>nc<span style='letter-spacing:.05pt'>i</span>dence<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> fr</span>ac<span style='letter-spacing:.05pt'>t</span>ures<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>v</span>e<span style='letter-spacing:-.05pt'>r</span><span style='letter-spacing:.05pt'>t</span>ébra<span style='letter-spacing:.05pt'>l</span>es,<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'> </span>non<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:-.05pt'> </span><span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span>hanche,<span style='letter-spacing:.05pt'> </span>a é<span style='letter-spacing:.05pt'>t</span>é dé<span style='letter-spacing:-.2pt'>m</span>on<span style='letter-spacing:.05pt'>tr</span>ée.</p>
<p class=AmmCorpsTexte>Lo<span style='letter-spacing:.05pt'>r</span>s<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>déc<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>i</span>on du cho<span style='letter-spacing:.05pt'>i</span>x du chlorhydrate de raloxifène ou d<span style='letter-spacing:.05pt'>’</span>au<span style='letter-spacing:.05pt'>tr</span>es<span style='letter-spacing:.05pt'> t</span>hé<span style='letter-spacing:.05pt'>r</span>apeu<span style='letter-spacing:.05pt'>ti</span>ques, <span style='letter-spacing:.05pt'>i</span>nc<span style='letter-spacing:.05pt'>l</span>uant<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>es<span style='letter-spacing:.05pt'>tr</span>o<span style='letter-spacing:-.1pt'>g</span>ènes, pour<span style='letter-spacing:.05pt'> </span>une <span style='letter-spacing: .05pt'>f</span>e<span style='letter-spacing:-.2pt'>mm</span>e<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>énop<span style='letter-spacing:-.05pt'>a</span>usée,<span style='letter-spacing:.05pt'> i</span>l<span style='letter-spacing:.05pt'> </span>con<span style='letter-spacing: -.15pt'>v</span><span style='letter-spacing:.05pt'>i</span>endra<span style='letter-spacing:.05pt'> </span>de prendre<span style='letter-spacing: .05pt'> </span>en<span style='letter-spacing:.05pt'> </span>co<span style='letter-spacing:-.2pt'>m</span>p<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>s<span style='letter-spacing:-.1pt'>y</span><span style='letter-spacing:-.2pt'>m</span>p<span style='letter-spacing:.05pt'>t</span>ô<span style='letter-spacing:-.2pt'>m</span>es<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>énop<span style='letter-spacing:-.05pt'>a</span>use,<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>e<span style='letter-spacing:.05pt'>ff</span>e<span style='letter-spacing:.05pt'>t</span>s sur<span style='letter-spacing:.05pt'> l’</span>u<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing: .05pt'>r</span>us et<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing:.05pt'> </span>se<span style='letter-spacing:.05pt'>i</span>n,<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> ri</span>sques<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> </span>béné<span style='letter-spacing: .05pt'>fi</span>ces<span style='letter-spacing:.05pt'> </span>ca<span style='letter-spacing:.05pt'>r</span>d<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.05pt'>o</span><span style='letter-spacing:-.2pt'>-</span><span style='letter-spacing:-.1pt'>v</span>ascu<span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'>ir</span>es<span style='letter-spacing:.05pt'> </span>(<span style='letter-spacing:-.1pt'>vo</span><span style='letter-spacing:.2pt'>i</span>r<span style='letter-spacing:.05pt'> r</span>ub<span style='letter-spacing:.05pt'>ri</span>que<span style='letter-spacing:.05pt'> </span>5.1<span style='letter-spacing:.05pt'>)</span>.</p>
<p class="AmmAnnexeTitre2"><a name="RcpPosoAdmin">4.2. Posologie et mode d'administration</a></p>
<p class=AmmAnnexeTitre3>Poso<span style='letter-spacing:.05pt'>l</span>o<span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>i</span>e</p>
<p class=AmmCorpsTexte>La<span style='letter-spacing:.05pt'> </span>poso<span style='letter-spacing:.05pt'>l</span>o<span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>i</span>e<span style='letter-spacing:.05pt'> r</span>eco<span style='letter-spacing:-.2pt'>mm</span>andée<span style='letter-spacing:.05pt'> </span>est<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> </span>un co<span style='letter-spacing:-.2pt'>m</span>p<span style='letter-spacing:.05pt'>ri</span><span style='letter-spacing:-.2pt'>m</span>é<span style='letter-spacing:.05pt'> </span>par<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:.15pt'>j</span>ou<span style='letter-spacing:.05pt'>r</span>, par<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>v</span>o<span style='letter-spacing:.05pt'>i</span>e<span style='letter-spacing:.05pt'> </span>o<span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:.05pt'>l</span>e, qui<span style='letter-spacing:.05pt'> </span>peut<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>ri</span>s<span style='letter-spacing:.05pt'> </span>à<span style='letter-spacing:.05pt'> </span>n<span style='letter-spacing:-.2pt'>'</span><span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.2pt'>m</span>po<span style='letter-spacing:.05pt'>rt</span>e que<span style='letter-spacing:.05pt'>ll</span>e<span style='letter-spacing: .05pt'> </span>heure<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:.15pt'>j</span>ou<span style='letter-spacing:.05pt'>r</span>née, a<span style='letter-spacing:-.1pt'>v</span>an<span style='letter-spacing:.05pt'>t</span>, pendant<span style='letter-spacing:.05pt'> </span>ou ap<span style='letter-spacing: .05pt'>r</span>ès<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> r</span>epas. En <span style='letter-spacing: .05pt'>r</span>a<span style='letter-spacing:.05pt'>i</span>son de<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>na<span style='letter-spacing:.05pt'>t</span>u<span style='letter-spacing:.05pt'>r</span>e<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>pa<span style='letter-spacing:.05pt'>t</span>ho<span style='letter-spacing:.05pt'>l</span>o<span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>i</span>e, le chlorhydrate de raloxifène<span style='letter-spacing:.05pt'> </span>est<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'>ti</span>né<span style='letter-spacing:.05pt'> </span>à<span style='letter-spacing:.05pt'> </span>une<span style='letter-spacing:.05pt'> </span>u<span style='letter-spacing:.05pt'>tili</span>sa<span style='letter-spacing:.05pt'>ti</span>on de<span style='letter-spacing:.05pt'> l</span>on<span style='letter-spacing: -.1pt'>g</span>ue<span style='letter-spacing:.05pt'> </span>du<span style='letter-spacing:.05pt'>r</span>ée.</p>
<p class=AmmCorpsTexte><span style='letter-spacing:-.05pt'>U</span>ne supplé<span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'> </span>ca<span style='letter-spacing:.05pt'>l</span>c<span style='letter-spacing:.05pt'>i</span>um<span style='letter-spacing:-.2pt'> </span>et<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.15pt'>v</span><span style='letter-spacing:.05pt'>it</span>a<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>ne D<span style='letter-spacing:-.05pt'> </span>est<span style='letter-spacing: .05pt'> </span><span style='letter-spacing:-.1pt'>g</span>éné<span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> r</span>eco<span style='letter-spacing:-.2pt'>mm</span>andée<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> f</span>e<span style='letter-spacing:-.2pt'>mm</span>es a<span style='letter-spacing:-.1pt'>y</span>ant<span style='letter-spacing: .05pt'> </span>un appo<span style='letter-spacing:.05pt'>r</span>t<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'>li</span><span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:.05pt'>ir</span>e<span style='letter-spacing:.05pt'> f</span>a<span style='letter-spacing:.05pt'>i</span>b<span style='letter-spacing:.05pt'>l</span>e.</p>
<p class=AmmAnnexeTitre4>Fe<span style='letter-spacing:-.05pt'>mm</span>es<span style='letter-spacing:.05pt'> </span>âgées<span style='letter-spacing:.05pt; text-decoration:none'> </span><span style='text-decoration:none'>:</span></p>
<p class=AmmCorpsTexte><span style='letter-spacing:-.2pt'>I</span>l<span style='letter-spacing:.05pt'> </span>n<span style='letter-spacing:-.2pt'>'</span>est<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> </span>nécessa<span style='letter-spacing:.05pt'>ir</span>e<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:-.2pt'>'</span>adap<span style='letter-spacing:.05pt'>t</span>er<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>poso<span style='letter-spacing:.05pt'>l</span>o<span style='letter-spacing:-.15pt'>g</span><span style='letter-spacing:.05pt'>i</span>e<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> f</span>e<span style='letter-spacing:-.2pt'>mm</span>es<span style='letter-spacing:.05pt'> </span>â<span style='letter-spacing:-.1pt'>g</span>ées.</p>
<p class=AmmAnnexeTitre4><span style='letter-spacing:.05pt'>I</span>nsu<span style='letter-spacing:.05pt'>ffi</span>sance<span style='letter-spacing:.05pt'> </span>réna<span style='letter-spacing:.05pt'>l</span>e<span style='text-decoration: none'> :</span></p>
<p class=AmmCorpsTexte>RALOXIFENE CRISTERS <span style='letter-spacing:.05pt'>n</span>e <span style='letter-spacing:.05pt'>do</span><span style='letter-spacing:-.05pt'>i</span>t<span style='letter-spacing:.05pt'> p</span><span style='letter-spacing:-.05pt'>a</span>s<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> u</span>t<span style='letter-spacing:.05pt'>ili</span>sé<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> </span>pa<span style='letter-spacing:.05pt'>ti</span>en<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>y</span>ant<span style='letter-spacing:.05pt'> </span>une <span style='letter-spacing:.05pt'>i</span>nsuf<span style='letter-spacing:.05pt'>fi</span>sance<span style='letter-spacing:.05pt'> r</span>éna<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing: .05pt'> </span>sé<span style='letter-spacing:-.1pt'>v</span>è<span style='letter-spacing:.05pt'>r</span>e<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>(</span><span style='letter-spacing:-.1pt'>vo</span><span style='letter-spacing:.2pt'>i</span>r<span style='letter-spacing:.05pt'> r</span>ub<span style='letter-spacing:.05pt'>ri</span>que<span style='letter-spacing:.05pt'> </span>4.3<span style='letter-spacing:.05pt'>)</span>. <span style='letter-spacing:-.05pt'>C</span>hez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> </span>pa<span style='letter-spacing:.05pt'>ti</span>en<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:.05pt'> </span>présen<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:-.05pt'>n</span>t<span style='letter-spacing:.05pt'> </span>une <span style='letter-spacing:.05pt'>i</span>nsuf<span style='letter-spacing:.05pt'>fi</span>sance<span style='letter-spacing:.05pt'> r</span>éna<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing: .05pt'> </span><span style='letter-spacing:-.2pt'>m</span>odé<span style='letter-spacing:.05pt'>r</span>ée<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> l</span>é<span style='letter-spacing:-.1pt'>g</span>è<span style='letter-spacing:.05pt'>r</span>e,<span style='letter-spacing:-.05pt'> </span>RALOXIFENE CRISTERS doit<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>u<span style='letter-spacing:.05pt'>tili</span>sé<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>v</span>ec p<span style='letter-spacing:.05pt'>r</span>udence.</p>
<p class=AmmAnnexeTitre4>Insuffisance hépatique<span style='text-decoration: none'> :</span></p>
<p class=AmmCorpsTexte>RALOXIFENE CRISTERS ne doit pas être utilisé chez les patients ayant une insuffisance hépatique (voir rubrique 4.3 et 4.4).</p>
<p class=AmmAnnexeTitre4>Popu<span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'>ti</span>on péd<span style='letter-spacing:.05pt'>i</span>a<span style='letter-spacing: .05pt'>t</span>r<span style='letter-spacing:.05pt'>i</span>que<span style='text-decoration:none'> :</span></p>
<p class=AmmCorpsTexte>RALOXIFENE CRISTERS ne doit pas être utilisé chez les enfants, quel que soit leur âge. Il n’y a pas d’utilisation justifiée de RALOXIFENE CRISTERS dans la population pédiatrique.</p>
<p class="AmmAnnexeTitre2"><a name="RcpContreIndic">4.3. Contre-indications</a></p>
<p class=AmmCorpsTexte><span style='letter-spacing:-.05pt'>H</span>ype<span style='letter-spacing:.05pt'>r</span>sens<span style='letter-spacing:.05pt'>i</span>b<span style='letter-spacing:.05pt'>ilit</span>é<span style='letter-spacing:.05pt'> </span>à<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>subs<span style='letter-spacing:.05pt'>t</span>ance<span style='letter-spacing:.05pt'> </span>ac<span style='letter-spacing:.05pt'>ti</span>ve<span style='letter-spacing:.05pt'> </span>ou<span style='letter-spacing:.05pt'> </span>à <span style='letter-spacing:.05pt'>l’</span>un<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:-.05pt'>e</span>s<span style='letter-spacing:.05pt'> </span>exc<span style='letter-spacing:.05pt'>i</span>p<span style='letter-spacing:.05pt'>i</span>en<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:.05pt'> li</span>s<span style='letter-spacing:.05pt'>t</span>és<span style='letter-spacing:.05pt'> </span>dans <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> r</span>ub<span style='letter-spacing:.05pt'>r</span><span style='letter-spacing:-.05pt'>i</span>que<span style='letter-spacing:.05pt'> </span>6.1. <span style='letter-spacing:-.05pt'>N</span>e<span style='letter-spacing:.05pt'> </span>doit<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>u<span style='letter-spacing:.05pt'>tili</span>sé<span style='letter-spacing:.05pt'> </span>chez <span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> f</span>e<span style='letter-spacing:-.2pt'>mm</span>es<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'> </span>âge<span style='letter-spacing:.05pt'> </span>de proc<span style='letter-spacing:.05pt'>r</span>éer<span style='letter-spacing:-.05pt'> </span><span style='letter-spacing:.05pt'>(</span>vo<span style='letter-spacing:.2pt'>i</span>r<span style='letter-spacing:.05pt'> r</span>ub<span style='letter-spacing:.05pt'>ri</span>que 4.6<span style='letter-spacing:.05pt'>)</span>.</p>
<p class=AmmCorpsTexte><span style='letter-spacing:-.05pt'>A</span>n<span style='letter-spacing:.05pt'>t</span>écéden<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:.05pt'> </span>d’acc<span style='letter-spacing:.05pt'>i</span>den<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:.05pt'> t</span>hro<span style='letter-spacing:-.2pt'>m</span>b<span style='letter-spacing:-.05pt'>o</span><span style='letter-spacing:-.2pt'>-</span>e<span style='letter-spacing:-.2pt'>m</span>bo<span style='letter-spacing:.05pt'>li</span>ques<span style='letter-spacing:.05pt'> </span>ve<span style='letter-spacing:.05pt'>i</span>neux ou acc<span style='letter-spacing: .05pt'>i</span>dent<span style='letter-spacing:.05pt'> t</span>h<span style='letter-spacing:.05pt'>r</span>o<span style='letter-spacing:-.2pt'>m</span>boe<span style='letter-spacing:-.2pt'>m</span>bo<span style='letter-spacing:.05pt'>li</span>que<span style='letter-spacing:.05pt'> </span>ve<span style='letter-spacing:.05pt'>i</span>neux en évo<span style='letter-spacing:.05pt'>l</span>u<span style='letter-spacing: .05pt'>ti</span>on, <span style='letter-spacing:.05pt'>i</span>nc<span style='letter-spacing:.05pt'>l</span>uant<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> t</span>h<span style='letter-spacing:.05pt'>r</span>o<span style='letter-spacing:-.2pt'>m</span>bose<span style='letter-spacing:.05pt'> </span>ve<span style='letter-spacing:.05pt'>i</span>neuse<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>r</span>o<span style='letter-spacing:.05pt'>f</span>onde, <span style='letter-spacing:.05pt'>l’</span>e<span style='letter-spacing:-.2pt'>m</span>bo<span style='letter-spacing:.05pt'>li</span>e<span style='letter-spacing:.05pt'> </span>pu<span style='letter-spacing:.05pt'>l</span><span style='letter-spacing:-.2pt'>m</span>ona<span style='letter-spacing:.05pt'>ir</span>e<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> t</span>hro<span style='letter-spacing:-.2pt'>m</span>bose<span style='letter-spacing:.05pt'> </span>ve<span style='letter-spacing:.05pt'>i</span>neuse <span style='letter-spacing:.05pt'>r</span>é<span style='letter-spacing:.05pt'>ti</span>n<span style='letter-spacing:.05pt'>i</span>enne.</p>
<p class=AmmCorpsTexte><span style='letter-spacing:-.2pt'>I</span>nsuf<span style='letter-spacing:.05pt'>fi</span>sance<span style='letter-spacing:.05pt'> </span>hépa<span style='letter-spacing:.05pt'>ti</span>que y co<span style='letter-spacing:-.2pt'>m</span>pr<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'> </span>choles<span style='letter-spacing:.05pt'>t</span>ase. <span style='letter-spacing:-.2pt'>I</span>nsuf<span style='letter-spacing:.05pt'>fi</span>sance<span style='letter-spacing:.05pt'> r</span>éna<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing: .05pt'> </span>sévè<span style='letter-spacing:.05pt'>r</span>e.</p>
<p class=AmmCorpsTexte>Sa<span style='letter-spacing:.05pt'>i</span>gne<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>gén<span style='letter-spacing:.05pt'>it</span>al<span style='letter-spacing:.05pt'> i</span>nexp<span style='letter-spacing:.05pt'>li</span>qué.</p>
<p class=AmmCorpsTexte>Le chlorhydrate de raloxifène<span style='letter-spacing: .05pt'> </span>ne doit<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>u<span style='letter-spacing:.05pt'>tili</span>sé<span style='letter-spacing:.05pt'> </span>chez <span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> </span>pa<span style='letter-spacing:.05pt'>ti</span>en<span style='letter-spacing:.05pt'>t</span>es<span style='letter-spacing:.05pt'> </span>ayant<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span>s<span style='letter-spacing:.05pt'>i</span>gnes<span style='letter-spacing:.05pt'> </span>ou<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:-.05pt'>e</span>s<span style='letter-spacing:.05pt'> </span>sy<span style='letter-spacing:-.2pt'>m</span>p<span style='letter-spacing:.05pt'>t</span>ô<span style='letter-spacing:-.2pt'>m</span>es<span style='letter-spacing:.05pt'> </span>de cancer<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>l’</span>endo<span style='letter-spacing:-.2pt'>m</span>è<span style='letter-spacing:.05pt'>tr</span>e, <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span>sécur<span style='letter-spacing:.05pt'>it</span>é<span style='letter-spacing:.05pt'> </span>d’e<span style='letter-spacing:-.2pt'>m</span>p<span style='letter-spacing:.05pt'>l</span>oi<span style='letter-spacing:.05pt'> </span>dans ce<span style='letter-spacing:.05pt'> </span>g<span style='letter-spacing:.05pt'>r</span>oupe<span style='letter-spacing:-.05pt'> </span>de pa<span style='letter-spacing:.05pt'>ti</span>en<span style='letter-spacing:.05pt'>t</span>es<span style='letter-spacing:.05pt'> </span>n’ayant<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'> </span>suf<span style='letter-spacing:.05pt'>fi</span>sa<span style='letter-spacing:-.2pt'>mm</span>ent<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>udiée.</p>
<p class="AmmAnnexeTitre2"><a name="RcpMisesEnGarde">4.4. Mises en garde spéciales et précautions d'emploi</a></p>
<p class=AmmCorpsTexte><a name="_Toc142278920">Le<span style='letter-spacing: .05pt'> chlorhydrate de r</span>a<span style='letter-spacing:.05pt'>l</span>oxi<span style='letter-spacing:.05pt'>f</span>ène est<span style='letter-spacing:.05pt'> </span>assoc<span style='letter-spacing:.05pt'>i</span>é<span style='letter-spacing: .05pt'> </span>à<span style='letter-spacing:.05pt'> </span>un<span style='letter-spacing:.05pt'> </span>r<span style='letter-spacing:.05pt'>i</span>sque acc<span style='letter-spacing:.05pt'>r</span>u<span style='letter-spacing: .05pt'> </span>d’acc<span style='letter-spacing:.05pt'>i</span>dent<span style='letter-spacing:.05pt'> t</span>hro<span style='letter-spacing:-.2pt'>m</span>b<span style='letter-spacing:-.1pt'>o</span><span style='letter-spacing:-.2pt'>-</span>e<span style='letter-spacing:-.2pt'>m</span>bo<span style='letter-spacing:.05pt'>li</span>que<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>v</span>e<span style='letter-spacing:.05pt'>i</span>neux qui<span style='letter-spacing:.05pt'> </span>est<span style='letter-spacing:.05pt'> i</span>den<span style='letter-spacing:.05pt'>ti</span>que<span style='letter-spacing:.05pt'> </span>à ce<span style='letter-spacing:.05pt'>l</span>ui<span style='letter-spacing: .05pt'> r</span>appor<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>v</span>ec<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing:.05pt'> tr</span>a<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>hor<span style='letter-spacing:-.2pt'>m</span>onal<span style='letter-spacing:.05pt'> </span>subs<span style='letter-spacing:.05pt'>tit</span>u<span style='letter-spacing:.05pt'>ti</span>f<span style='letter-spacing:.05pt'> (</span><span style='letter-spacing:.1pt'>T</span><span style='letter-spacing:-.05pt'>H</span>S<span style='letter-spacing:.05pt'>)</span>.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>L</span>e<span style='letter-spacing:.05pt'> r</span>apport<span style='letter-spacing:.05pt'> </span>béné<span style='letter-spacing:.05pt'>fi</span>ce<span style='letter-spacing:-.3pt'>-</span><span style='letter-spacing:.05pt'>ri</span>sque<span style='letter-spacing:.05pt'> </span>do<span style='letter-spacing:.05pt'>i</span>t<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>ri</span>s en<span style='letter-spacing:.05pt'> </span>co<span style='letter-spacing: -.2pt'>m</span>p<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> </span>pa<span style='letter-spacing:.05pt'>ti</span>en<span style='letter-spacing:.05pt'>t</span>es<span style='letter-spacing:.05pt'> </span>présen<span style='letter-spacing:.05pt'>t</span>ant<span style='letter-spacing:.05pt'> </span>un<span style='letter-spacing:.05pt'> </span>r<span style='letter-spacing:.05pt'>i</span>sque d’acc<span style='letter-spacing: .05pt'>i</span>dent<span style='letter-spacing:.05pt'> t</span>hro<span style='letter-spacing:-.2pt'>m</span>b<span style='letter-spacing:-.15pt'>o</span><span style='letter-spacing:-.2pt'>-</span>e<span style='letter-spacing:-.2pt'>m</span>bo<span style='letter-spacing:.05pt'>li</span>que<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>v</span>e<span style='letter-spacing:.05pt'>i</span>neux que<span style='letter-spacing:.05pt'>ll</span>e<span style='letter-spacing: .05pt'> </span>qu<span style='letter-spacing:.05pt'>’</span>en s<span style='letter-spacing:.05pt'>o</span>it<span style='letter-spacing:.05pt'> l’</span>é<span style='letter-spacing:.05pt'>tio</span>l<span style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.2pt'>g</span><span style='letter-spacing:.05pt'>i</span>e.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>L</span>e<span style='letter-spacing:.05pt'> tr</span>a<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:-.2pt'>m</span>e<span style='letter-spacing:.05pt'>n</span>t <span style='letter-spacing:.05pt'>p</span><span style='letter-spacing:-.05pt'>a</span>r<span style='letter-spacing:.05pt'> </span>le chlorhydrate de raloxifène<span style='letter-spacing:.05pt'> </span>do<span style='letter-spacing:.05pt'>i</span>t<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> i</span>n<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'>rr</span>o<span style='letter-spacing:-.2pt'>m</span>pu en<span style='letter-spacing:.05pt'> </span>cas<span style='letter-spacing: .05pt'> </span>de <span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>l</span>ad<span style='letter-spacing:.05pt'>i</span>e<span style='letter-spacing:.05pt'> </span>ou<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:-.05pt'> </span>s<span style='letter-spacing:.05pt'>it</span>ua<span style='letter-spacing:.05pt'>ti</span>on en<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>î</span>nant<span style='letter-spacing:.05pt'> </span>une<span style='letter-spacing:.05pt'> i</span><span style='letter-spacing:-.2pt'>mm</span>ob<span style='letter-spacing:.05pt'>ili</span>sa<span style='letter-spacing:.05pt'>ti</span>on p<span style='letter-spacing:.05pt'>r</span>o<span style='letter-spacing:.05pt'>l</span>on<span style='letter-spacing:-.1pt'>g</span>ée. <span style='letter-spacing:-.05pt'>C</span>eci<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>l</span>us<span style='letter-spacing:.05pt'> t</span>ôt<span style='letter-spacing:.05pt'> </span>poss<span style='letter-spacing:.05pt'>i</span>b<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> </span>ou dans<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing: .05pt'> </span>3 <span style='letter-spacing:.15pt'>j</span>ou<span style='letter-spacing:.05pt'>r</span>s<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>r</span>écédant<span style='letter-spacing:.05pt'> </span>une <span style='letter-spacing:.05pt'>i</span><span style='letter-spacing: -.2pt'>mm</span>ob<span style='letter-spacing:.05pt'>ili</span>sa<span style='letter-spacing:.05pt'>ti</span>on p<span style='letter-spacing:.05pt'>r</span>o<span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:-.2pt'>mm</span>ée. La<span style='letter-spacing:.05pt'> r</span>ep<span style='letter-spacing:.05pt'>ri</span>se<span style='letter-spacing: .05pt'> </span>du <span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>ne<span style='letter-spacing:.05pt'> </span>pou<span style='letter-spacing:.05pt'>rr</span>a<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>v</span>o<span style='letter-spacing:.05pt'>i</span>r<span style='letter-spacing:.05pt'> li</span>eu qu<span style='letter-spacing:.05pt'>’</span>ap<span style='letter-spacing:.05pt'>r</span>ès<span style='letter-spacing:.05pt'> r</span>éso<span style='letter-spacing:.05pt'>l</span>u<span style='letter-spacing:.05pt'>ti</span>on des causes<span style='letter-spacing:.05pt'> i</span>n<span style='letter-spacing: .05pt'>iti</span>a<span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> </span>de son<span style='letter-spacing:-.05pt'> </span>a<span style='letter-spacing:.05pt'>rr</span>êt<span style='letter-spacing: .05pt'> </span>et<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> r</span>epr<span style='letter-spacing:.05pt'>i</span>se<span style='letter-spacing:.05pt'> </span>d’une <span style='letter-spacing:-.2pt'>m</span>obi<span style='letter-spacing:.05pt'>lit</span>é<span style='letter-spacing:.05pt'> </span>co<span style='letter-spacing:-.2pt'>m</span>p<span style='letter-spacing:.05pt'>l</span>è<span style='letter-spacing:.05pt'>t</span>e.</a></p>
<p class=AmmCorpsTexte><span style='letter-spacing:-.05pt'>D</span>ans une é<span style='letter-spacing:.05pt'>t</span>ude condu<span style='letter-spacing:-.05pt'>i</span><span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing:-.1pt'> </span>des<span style='letter-spacing:.05pt'> f</span>e<span style='letter-spacing:-.2pt'>mm</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>énop<span style='letter-spacing:-.05pt'>a</span>usées<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>y</span>ant<span style='letter-spacing:.05pt'> </span>une <span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>l</span>ad<span style='letter-spacing:.05pt'>i</span>e<span style='letter-spacing:.05pt'> </span>corona<span style='letter-spacing:.05pt'>ri</span>enne connue<span style='letter-spacing:-.05pt'> </span>ou un<span style='letter-spacing: .05pt'> </span>r<span style='letter-spacing:.05pt'>i</span>sque acc<span style='letter-spacing:.05pt'>r</span>u<span style='letter-spacing:.05pt'> </span>d’acc<span style='letter-spacing:.05pt'>i</span>den<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:.05pt'> </span>corona<span style='letter-spacing:.05pt'>ri</span>ens,<span style='letter-spacing:.05pt'> </span>co<span style='letter-spacing:-.2pt'>m</span>pa<span style='letter-spacing:.05pt'>r</span>é<span style='letter-spacing:.05pt'> </span>au<span style='letter-spacing:.05pt'> </span>placebo,<span style='letter-spacing:.05pt'> </span>le<span style='letter-spacing:.05pt'> </span>chlorhydrate de raloxifène n’a<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing: .05pt'> </span><span style='letter-spacing:-.2pt'>m</span>odi<span style='letter-spacing:.05pt'>fi</span>é <span style='letter-spacing:.05pt'>l’i</span>nc<span style='letter-spacing:.05pt'>i</span>dence<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> i</span>nfa<span style='letter-spacing:.05pt'>r</span>c<span style='letter-spacing:.05pt'>t</span>us du <span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:-.1pt'>y</span>oca<span style='letter-spacing:.05pt'>r</span>de, des<span style='letter-spacing:.05pt'> </span>hosp<span style='letter-spacing: .05pt'>it</span>a<span style='letter-spacing:.05pt'>li</span>sa<span style='letter-spacing:.05pt'>ti</span>ons<span style='letter-spacing:.05pt'> </span>pour<span style='letter-spacing:.05pt'> </span>s<span style='letter-spacing:-.1pt'>y</span>nd<span style='letter-spacing:.05pt'>r</span>o<span style='letter-spacing:-.2pt'>m</span>e<span style='letter-spacing:.05pt'> </span>co<span style='letter-spacing:.05pt'>r</span>ona<span style='letter-spacing:.05pt'>ri</span>en a<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>g</span>u, de<span style='letter-spacing:.05pt'> l</span>a <span style='letter-spacing:-.2pt'>m</span>or<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:.05pt'>lit</span>é<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>l</span>oba<span style='letter-spacing:.05pt'>l</span>e,<span style='letter-spacing:.05pt'> </span>y<span style='letter-spacing:-.15pt'> </span>co<span style='letter-spacing:-.2pt'>m</span>pr<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>or<span style='letter-spacing: .05pt'>t</span>a<span style='letter-spacing:.05pt'>lit</span>é<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>l</span>oba<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> </span>d’or<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>i</span>ne ca<span style='letter-spacing:.05pt'>r</span>d<span style='letter-spacing:.05pt'>i</span>o<span style='letter-spacing:-.15pt'>v</span>ascu<span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'>ir</span>e,<span style='letter-spacing:.05pt'> </span>ou<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:-.05pt'>e</span>s<span style='letter-spacing:.05pt'> </span>acc<span style='letter-spacing:.05pt'>i</span>den<span style='letter-spacing:.05pt'>t</span>s <span style='letter-spacing:-.1pt'>v</span>ascu<span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'>ir</span>es<span style='letter-spacing:.05pt'> </span>cé<span style='letter-spacing:.05pt'>r</span>ébraux.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>N</span>éan<span style='letter-spacing:-.2pt'>m</span>o<span style='letter-spacing:.05pt'>i</span>ns,<span style='letter-spacing:.05pt'> i</span>l<span style='letter-spacing:.05pt'> </span>y<span style='letter-spacing:-.1pt'> </span>a<span style='letter-spacing:.05pt'> </span>eu<span style='letter-spacing:.05pt'> </span>une<span style='letter-spacing:-.05pt'> </span>au<span style='letter-spacing:-.15pt'>g</span><span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:-.05pt'> </span><span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>or<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:.05pt'>lit</span>é<span style='letter-spacing:.05pt'> </span>par<span style='letter-spacing:.05pt'> </span>acc<span style='letter-spacing:.05pt'>i</span>d<span style='letter-spacing:-.15pt'>e</span>nt<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>v</span>ascu<span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'>ir</span>e cé<span style='letter-spacing:.05pt'>r</span>ébral<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> f</span>e<span style='letter-spacing:-.2pt'>mm</span>es<span style='letter-spacing:.05pt'> </span>sous chlorhydrate de raloxifène.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>L</span><span style='letter-spacing:.05pt'>’i</span>nc<span style='letter-spacing:.05pt'>i</span>dence<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>or<span style='letter-spacing: .05pt'>t</span>a<span style='letter-spacing:.05pt'>lit</span>é<span style='letter-spacing:.05pt'> </span>par<span style='letter-spacing:.05pt'> </span>acc<span style='letter-spacing:.05pt'>i</span>dent<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>v</span>ascu<span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'>ir</span>e<span style='letter-spacing:.05pt'> </span>cé<span style='letter-spacing:.05pt'>r</span>ébral a<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing: .05pt'> </span>de<span style='letter-spacing:.05pt'> </span>2,2 pour<span style='letter-spacing:.05pt'> </span>1000 <span style='letter-spacing:.05pt'>f</span>e<span style='letter-spacing:-.2pt'>mm</span>es<span style='letter-spacing:-.2pt'>-</span>année<span style='letter-spacing:.05pt'> </span>pour<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing:.05pt'> </span>chlorhydrate de raloxifène <span style='letter-spacing:-.1pt'>v</span>e<span style='letter-spacing:.05pt'>r</span>sus<span style='letter-spacing:.05pt'> </span>1,5 pour<span style='letter-spacing:.05pt'> </span>1000 <span style='letter-spacing:.05pt'>f</span>e<span style='letter-spacing: -.2pt'>mm</span>es<span style='letter-spacing:-.2pt'>-</span>année<span style='letter-spacing:.05pt'> </span>pour<span style='letter-spacing:.05pt'> l</span>e p<span style='letter-spacing:.05pt'>l</span>acebo <span style='letter-spacing: .05pt'>(</span><span style='letter-spacing:-.1pt'>v</span>o<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'> r</span>ub<span style='letter-spacing:.05pt'>ri</span>que<span style='letter-spacing:.05pt'> </span>4.8).<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>C</span>e<span style='letter-spacing:.05pt'> r</span>ésu<span style='letter-spacing:.05pt'>lt</span>at<span style='letter-spacing:.05pt'> </span>do<span style='letter-spacing:.05pt'>i</span>t<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>ri</span>s<span style='letter-spacing:.05pt'> </span>en co<span style='letter-spacing:-.2pt'>m</span>p<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'> l</span>o<span style='letter-spacing:.05pt'>r</span>s<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>r</span>esc<span style='letter-spacing:.05pt'>ri</span>p<span style='letter-spacing:.05pt'>ti</span>on du chlorhydrate de raloxifène chez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> f</span>e<span style='letter-spacing:-.2pt'>mm</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>énop<span style='letter-spacing:-.05pt'>a</span>usées<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>y</span>ant<span style='letter-spacing:.05pt'> </span>un<span style='letter-spacing:.05pt'> </span>an<span style='letter-spacing:.05pt'>t</span>écédent<span style='letter-spacing:.05pt'> </span>d’acc<span style='letter-spacing:.05pt'>i</span>dent<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>v</span>ascu<span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'>ir</span>e<span style='letter-spacing:.05pt'> </span>cé<span style='letter-spacing:.05pt'>r</span>ébral<span style='letter-spacing:.05pt'> </span>ou<span style='letter-spacing:.05pt'> </span>d’au<span style='letter-spacing:.05pt'>tr</span>es<span style='letter-spacing:.05pt'> f</span>ac<span style='letter-spacing:.05pt'>t</span>eurs de <span style='letter-spacing:.05pt'>ri</span>sque <span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.2pt'>m</span>por<span style='letter-spacing:.05pt'>t</span>an<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:.05pt'> </span>d’acc<span style='letter-spacing:.05pt'>i</span>dent<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>v</span>ascu<span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'>ir</span>e<span style='letter-spacing:.05pt'> </span>cé<span style='letter-spacing:.05pt'>r</span>ébra<span style='letter-spacing:.05pt'>l</span>,<span style='letter-spacing:.05pt'> t</span>e<span style='letter-spacing:.05pt'>l</span>s<span style='letter-spacing:.05pt'> </span>qu’un<span style='letter-spacing:.05pt'> </span>acc<span style='letter-spacing:.05pt'>i</span>dent<span style='letter-spacing:.05pt'> i</span>sché<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>que cé<span style='letter-spacing:.05pt'>r</span>ébral <span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>n</span><span style='letter-spacing:-.05pt'>s</span><span style='letter-spacing:.05pt'>ito</span>i<span style='letter-spacing:.05pt'>r</span>e<span style='letter-spacing:.05pt'> o</span>u<span style='letter-spacing:.05pt'> un</span>e<span style='letter-spacing:-.2pt'> </span><span style='letter-spacing:.05pt'>fib</span>r<span style='letter-spacing:.05pt'>ill</span>a<span style='letter-spacing:.05pt'>tio</span>n<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>a</span><span style='letter-spacing:.05pt'>u</span>r<span style='letter-spacing:.05pt'>i</span>c<span style='letter-spacing:.05pt'>u</span>la<span style='letter-spacing:.05pt'>ir</span>e.</p>
<p class=AmmCorpsTexte><span style='letter-spacing:-.2pt'>I</span>l<span style='letter-spacing:.05pt'> </span>n’est<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:-.1pt'>v</span><span style='letter-spacing:.05pt'>i</span>dence<span style='letter-spacing:.05pt'> </span>de pro<span style='letter-spacing:.05pt'>lif</span>é<span style='letter-spacing: .05pt'>r</span>a<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>endo<span style='letter-spacing:-.25pt'>m</span>é<span style='letter-spacing:.05pt'>tri</span>a<span style='letter-spacing:.05pt'>l</span>e.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:.1pt'>T</span>out sa<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>g</span>ne<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>d’or<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>i</span>ne <span style='letter-spacing:-.1pt'>g</span>én<span style='letter-spacing:.05pt'>it</span>a<span style='letter-spacing:.05pt'>l</span>e sur<span style='letter-spacing:-.1pt'>v</span>enant<span style='letter-spacing: .05pt'> </span>en<span style='letter-spacing:.05pt'> </span>cours<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>par<span style='letter-spacing:.05pt'> </span>le chlorhydrate de raloxifène<span style='letter-spacing:.05pt'> </span>cons<span style='letter-spacing:.05pt'>tit</span>ue un<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:-.1pt'>v</span>éne<span style='letter-spacing: -.2pt'>m</span>ent<span style='letter-spacing:.05pt'> i</span>na<span style='letter-spacing:.05pt'>tt</span>endu<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>e</span>t<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:-.1pt'>v</span><span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:.05pt'> f</span>a<span style='letter-spacing:.05pt'>ir</span>e<span style='letter-spacing:.05pt'> l’</span>ob<span style='letter-spacing:.1pt'>j</span>et d<span style='letter-spacing:.05pt'>’</span>exp<span style='letter-spacing: .05pt'>l</span>o<span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:.05pt'>ti</span>ons<span style='letter-spacing:.05pt'> </span>approfondies<span style='letter-spacing:.05pt'> </span>par<span style='letter-spacing:.05pt'> </span>un<span style='letter-spacing:.05pt'> </span>spéc<span style='letter-spacing:.05pt'>i</span>a<span style='letter-spacing:.05pt'>li</span>s<span style='letter-spacing:.05pt'>t</span>e.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>L</span>es<span style='letter-spacing:.05pt'> </span>deux<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>ti</span>o<span style='letter-spacing:.05pt'>l</span>o<span style='letter-spacing:-.15pt'>g</span><span style='letter-spacing:.05pt'>i</span>es<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>l</span>us <span style='letter-spacing:.05pt'>fr</span>éque<span style='letter-spacing:-.2pt'>mm</span>ent<span style='letter-spacing:.05pt'> </span>assoc<span style='letter-spacing:.05pt'>i</span>ées<span style='letter-spacing:.05pt'> </span>à des<span style='letter-spacing:.05pt'> </span>sa<span style='letter-spacing: .05pt'>i</span><span style='letter-spacing:-.1pt'>g</span>ne<span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:.05pt'> </span>d’or<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>i</span>ne <span style='letter-spacing:-.1pt'>g</span>én<span style='letter-spacing:.05pt'>it</span>a<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> </span>sous chlorhydrate de raloxifène ont é<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'> </span>une a<span style='letter-spacing:.05pt'>tr</span>ophie<span style='letter-spacing:.05pt'> </span>endo<span style='letter-spacing:-.25pt'>m</span>é<span style='letter-spacing:.05pt'>tri</span>a<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span>pol<span style='letter-spacing:-.1pt'>y</span>pes<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>l’</span>endo<span style='letter-spacing:-.2pt'>m</span>è<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> </span>na<span style='letter-spacing:.05pt'>t</span>u<span style='letter-spacing:.05pt'>r</span>e<span style='letter-spacing:.05pt'> </span>bén<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>g</span>ne. <span style='letter-spacing:-.05pt'>D</span>es<span style='letter-spacing:.05pt'> </span>po<span style='letter-spacing:.05pt'>l</span><span style='letter-spacing:-.1pt'>y</span>pes<span style='letter-spacing:.05pt'> </span>bén<span style='letter-spacing:.05pt'>i</span>ns<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> l’</span>endo<span style='letter-spacing:-.2pt'>m</span>è<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>ont é<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'> r</span>appor<span style='letter-spacing:.05pt'>t</span>és<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing:-.1pt'> </span>0,9<span style='letter-spacing:-.05pt'> </span>%<span style='letter-spacing:.05pt'> </span>des <span style='letter-spacing:.05pt'>f</span>e<span style='letter-spacing:-.2pt'>mm</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>énopausées<span style='letter-spacing:.05pt'> </span>qui<span style='letter-spacing:.05pt'> </span>ont<span style='letter-spacing:.05pt'> r</span>eçu du chlorhydrate de raloxifène<span style='letter-spacing:.05pt'> </span>pendant<span style='letter-spacing:.05pt'> </span>4 ans, co<span style='letter-spacing:-.2pt'>m</span>pa<span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:.05pt'>ti</span><span style='letter-spacing:-.1pt'>v</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>à<span style='letter-spacing:.05pt'> </span>0,3 %<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing: -.1pt'> </span><span style='letter-spacing:.05pt'>l</span>es <span style='letter-spacing:.05pt'>f</span>e<span style='letter-spacing:-.2pt'>mm</span>es<span style='letter-spacing:.05pt'> </span>qui ont <span style='letter-spacing:.05pt'>r</span>eçu<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>l</span>acebo.</p>
<p class=AmmCorpsTexte>Le chlorhydrate de raloxifène est<span style='letter-spacing: .05pt'> </span>pr<span style='letter-spacing:.05pt'>i</span>nc<span style='letter-spacing:.05pt'>i</span>pa<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>é<span style='letter-spacing:.05pt'>t</span>abol<span style='letter-spacing:.05pt'>i</span>sé<span style='letter-spacing:.05pt'> </span>par<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing:.05pt'> f</span>o<span style='letter-spacing:.05pt'>i</span>e.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>L</span><span style='letter-spacing:.05pt'>’</span>ad<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:-.05pt'> </span>doses<span style='letter-spacing:.05pt'> </span>uniques<span style='letter-spacing:.05pt'> </span>de chlorhydrate de raloxifène à<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span>pa<span style='letter-spacing:.05pt'>ti</span>en<span style='letter-spacing:.05pt'>t</span>es<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>y</span>ant<span style='letter-spacing:.05pt'> </span>une c<span style='letter-spacing:.05pt'>irr</span>hose<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> </span>une <span style='letter-spacing:.05pt'>i</span>nsuf<span style='letter-spacing: .05pt'>fi</span>sance<span style='letter-spacing:.05pt'> </span>hépa<span style='letter-spacing:.05pt'>ti</span>que <span style='letter-spacing:-.2pt'>m</span>odé<span style='letter-spacing:.05pt'>r</span>ée<span style='letter-spacing:.05pt'> (</span><span style='letter-spacing:-.05pt'>C</span>h<span style='letter-spacing:.05pt'>il</span><span style='letter-spacing:-.15pt'>d</span><span style='letter-spacing:-.2pt'>-</span>Pu<span style='letter-spacing:-.1pt'>g</span>h, c<span style='letter-spacing:.05pt'>l</span>asse<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>A</span>)<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>î</span>ne des<span style='letter-spacing:.05pt'> </span>concen<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>ons p<span style='letter-spacing:.05pt'>l</span>as<span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>ti</span>ques<span style='letter-spacing:.05pt'> </span>de chlorhydrate de raloxifène en<span style='letter-spacing:-.15pt'>v</span><span style='letter-spacing:.05pt'>ir</span>on<span style='letter-spacing:.05pt'> </span>2,5<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>f</span>o<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'> </span>supé<span style='letter-spacing:.05pt'>ri</span>eures<span style='letter-spacing:.05pt'> </span>à<span style='letter-spacing:.05pt'> </span>ce<span style='letter-spacing:.05pt'>ll</span>es des<span style='letter-spacing:.05pt'> t</span>é<span style='letter-spacing: -.2pt'>m</span>o<span style='letter-spacing:.05pt'>i</span>ns.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>L</span><span style='letter-spacing:.05pt'>’</span>au<span style='letter-spacing:-.15pt'>g</span><span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>est<span style='letter-spacing:.05pt'> </span>cor<span style='letter-spacing:.05pt'>r</span>é<span style='letter-spacing:.05pt'>l</span>ée<span style='letter-spacing:.05pt'> </span>aux<span style='letter-spacing:.05pt'> </span>concen<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>ons <span style='letter-spacing:.05pt'>d</span>e <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> b</span>i<span style='letter-spacing:.05pt'>lirub</span><span style='letter-spacing: -.05pt'>i</span><span style='letter-spacing:.05pt'>n</span>e <span style='letter-spacing:.05pt'>to</span>ta<span style='letter-spacing:.05pt'>l</span>e.<span style='letter-spacing:-.1pt'> </span>Par<span style='letter-spacing:.05pt'> </span>conséquen<span style='letter-spacing:.05pt'>t</span>, <span style='letter-spacing:.05pt'>l’u</span>t<span style='letter-spacing:.05pt'>ili</span>sa<span style='letter-spacing:.05pt'>tio</span>n<span style='letter-spacing:-.1pt'> </span>du chlorhydrate de raloxifène n’est<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> r</span>eco<span style='letter-spacing:-.2pt'>mm</span>andée<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> </span>pa<span style='letter-spacing:.05pt'>ti</span>en<span style='letter-spacing:-.05pt'>t</span>es<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>y</span>ant<span style='letter-spacing:.05pt'> </span>une <span style='letter-spacing:.05pt'>i</span>nsuf<span style='letter-spacing: .05pt'>fi</span>sance<span style='letter-spacing:.05pt'> </span>hépa<span style='letter-spacing:.05pt'>ti</span>qu<span style='letter-spacing:-.05pt'>e</span>. La b<span style='letter-spacing:.05pt'>ilir</span>ubine sé<span style='letter-spacing:.05pt'>ri</span>que <span style='letter-spacing:.05pt'>t</span>o<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:.05pt'>l</span>e,<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>g</span>a<span style='letter-spacing:-.2pt'>mm</span>a<span style='letter-spacing:-.25pt'>-</span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>l</span>u<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:-.1pt'>y</span>l<span style='letter-spacing:.05pt'> tr</span>ans<span style='letter-spacing:.05pt'>f</span>é<span style='letter-spacing:.05pt'>r</span>ases,<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>pho<span style='letter-spacing:-.05pt'>s</span>pha<span style='letter-spacing:.05pt'>t</span>ases<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'>l</span>ca<span style='letter-spacing:.05pt'>li</span>nes,<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>A</span>L<span style='letter-spacing:-.05pt'>A</span>T<span style='letter-spacing:.1pt'> </span>et <span style='letter-spacing:-.05pt'>A</span>S<span style='letter-spacing:-.05pt'>A</span>T<span style='letter-spacing:.1pt'> </span>de<span style='letter-spacing:-.1pt'>v</span><span style='letter-spacing:.05pt'>r</span>ont<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>tr</span>o<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>sur<span style='letter-spacing:-.1pt'>v</span>e<span style='letter-spacing:.05pt'>ill</span>ées<span style='letter-spacing:.05pt'> </span>au<span style='letter-spacing:.05pt'> </span>cours<span style='letter-spacing:.05pt'> </span>du<span style='letter-spacing:.05pt'> </span>t<span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>si<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>v</span>a<span style='letter-spacing:.05pt'>l</span>eurs<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:-.1pt'>v</span>ées<span style='letter-spacing:.05pt'> </span>sont obse<span style='letter-spacing:.05pt'>r</span><span style='letter-spacing:-.1pt'>v</span>ées.</p>
<p class=AmmCorpsTexte><span style='letter-spacing:-.05pt'>D</span>es<span style='letter-spacing:.05pt'> </span>donn<span style='letter-spacing:-.05pt'>é</span>es<span style='letter-spacing:.05pt'> </span>c<span style='letter-spacing:.05pt'>li</span>n<span style='letter-spacing:.05pt'>i</span>ques<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'> </span>no<span style='letter-spacing:-.25pt'>m</span>bre<span style='letter-spacing:.05pt'> li</span><span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>it</span>é<span style='letter-spacing:.05pt'> </span>su<span style='letter-spacing:-.15pt'>g</span><span style='letter-spacing:-.1pt'>g</span>è<span style='letter-spacing:.05pt'>r</span>ent<span style='letter-spacing:.05pt'> </span>que chez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing: .05pt'>l</span>es<span style='letter-spacing:.05pt'> </span>pa<span style='letter-spacing:.05pt'>ti</span>en<span style='letter-spacing:.05pt'>t</span>es<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>y</span>ant<span style='letter-spacing:.05pt'> </span>un<span style='letter-spacing:.05pt'> </span>an<span style='letter-spacing:.05pt'>t</span>écédent d<span style='letter-spacing:.05pt'>’</span>h<span style='letter-spacing:-.1pt'>y</span>pe<span style='letter-spacing:.05pt'>rtri</span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>l</span><span style='letter-spacing:-.1pt'>y</span>cé<span style='letter-spacing:.05pt'>ri</span>dé<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>e<span style='letter-spacing:.05pt'> (</span>&gt; 5,6 <span style='letter-spacing: -.2pt'>mm</span>o<span style='letter-spacing:.05pt'>l/l</span>)<span style='letter-spacing:.05pt'> i</span>ndu<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:.05pt'> </span>par<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>œ</span>s<span style='letter-spacing:.05pt'>tr</span>o<span style='letter-spacing:-.15pt'>g</span>ènes<span style='letter-spacing:.05pt'> </span>ad<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:-.05pt'>t</span><span style='letter-spacing:.05pt'>r</span>és<span style='letter-spacing:.05pt'> </span>par<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>v</span>o<span style='letter-spacing:.05pt'>i</span>e<span style='letter-spacing:.05pt'> </span>ora<span style='letter-spacing:.05pt'>l</span>e,<span style='letter-spacing:.05pt'> l</span>e chlorhydrate de raloxifène pour<span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:.05pt'>i</span>t<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>assoc<span style='letter-spacing:.05pt'>i</span>é<span style='letter-spacing:.05pt'> </span>à<span style='letter-spacing:.05pt'> </span>une au<span style='letter-spacing:-.15pt'>g</span><span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.25pt'>m</span>a<span style='letter-spacing:.05pt'>r</span>quée<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> tri</span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>l</span><span style='letter-spacing:-.1pt'>y</span>cé<span style='letter-spacing:.05pt'>ri</span>des<span style='letter-spacing:.05pt'> </span>sé<span style='letter-spacing:.05pt'>ri</span>ques.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>L</span>e<span style='letter-spacing:.05pt'> t</span>aux<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>tri</span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>l</span><span style='letter-spacing:-.1pt'>y</span>cé<span style='letter-spacing:.05pt'>ri</span>des<span style='letter-spacing:.05pt'> </span>sé<span style='letter-spacing:.05pt'>ri</span>ques<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span>pa<span style='letter-spacing:.05pt'>ti</span>en<span style='letter-spacing:.05pt'>t</span>es<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>y</span>ant<span style='letter-spacing:.05pt'> </span>un<span style='letter-spacing:.05pt'> </span>tel<span style='letter-spacing:.05pt'> </span>an<span style='letter-spacing:.05pt'>t</span>écédent<span style='letter-spacing:.05pt'> </span>doit<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>sur<span style='letter-spacing:-.1pt'>v</span>e<span style='letter-spacing:.05pt'>ill</span>é<span style='letter-spacing:.05pt'> l</span>ors<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span>pr<span style='letter-spacing:.05pt'>i</span>se<span style='letter-spacing: .05pt'> </span>de chlorhydrate de raloxifène.</p>
<p class=AmmCorpsTexte>La<span style='letter-spacing:.05pt'> </span>sécur<span style='letter-spacing:.05pt'>it</span>é<span style='letter-spacing:.05pt'> </span>d’e<span style='letter-spacing:-.2pt'>m</span>p<span style='letter-spacing:.05pt'>l</span>oi d<span style='letter-spacing:.05pt'>e </span>chlorhydrate de raloxifène chez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> </span>pa<span style='letter-spacing:.05pt'>ti</span>en<span style='letter-spacing:.05pt'>t</span>es<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>y</span>ant<span style='letter-spacing:.05pt'> </span>un<span style='letter-spacing:.05pt'> </span>cancer<span style='letter-spacing:.05pt'> </span>du<span style='letter-spacing:.05pt'> </span>se<span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'> </span>n’a<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'> </span>suf<span style='letter-spacing:.05pt'>fi</span>sa<span style='letter-spacing:-.2pt'>mm</span>ent é<span style='letter-spacing:.05pt'>t</span>ud<span style='letter-spacing:.05pt'>i</span>ée. <span style='letter-spacing:-.05pt'>A</span>ucune<span style='letter-spacing:.05pt'> </span>donnée<span style='letter-spacing:.05pt'> </span>n<span style='letter-spacing:.05pt'>’</span>est<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:.05pt'>i</span>spon<span style='letter-spacing:.05pt'>i</span>b<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> </span>conce<span style='letter-spacing:.05pt'>r</span>nant<span style='letter-spacing:.05pt'> l’</span>u<span style='letter-spacing:.05pt'>tili</span>sa<span style='letter-spacing:.05pt'>ti</span>on conco<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing: .05pt'>it</span>an<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:-.1pt'>e </span>chlorhydrate de raloxifène et<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>r</span>odu<span style='letter-spacing:.05pt'>it</span>s des<span style='letter-spacing:.05pt'>ti</span>nés<span style='letter-spacing:.05pt'> </span>au<span style='letter-spacing:.05pt'> tr</span>a<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>du<span style='letter-spacing:.05pt'> </span>cancer<span style='letter-spacing:.05pt'> </span>du<span style='letter-spacing:.05pt'> </span>se<span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'> </span>à un<span style='letter-spacing:.05pt'> </span>s<span style='letter-spacing:.05pt'>t</span>ade précoce ou<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing: -.1pt'>v</span>ancé.<span style='letter-spacing:.05pt'> </span></p>
<p class=AmmCorpsTexte><span style='letter-spacing:-.05pt'>E</span>n<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>c</span>onséquence<span style='letter-spacing:.05pt'> </span>chlorhydrate de raloxifène peut ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>u<span style='letter-spacing:.05pt'>tili</span>sé,<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'> tr</span>a<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>ou<span style='letter-spacing:.05pt'> </span>pré<span style='letter-spacing:-.1pt'>v</span>en<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:-.05pt'> </span><span style='letter-spacing:.05pt'>l</span><span style='letter-spacing:-.2pt'>'</span>os<span style='letter-spacing:.05pt'>t</span>éoporose,<span style='letter-spacing:.05pt'> </span>seu<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>si<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing:.05pt'> tr</span>a<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>pour <span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> </span>cancer<span style='letter-spacing:.05pt'> </span>du se<span style='letter-spacing:.05pt'>i</span>n, <span style='letter-spacing: .05pt'></span>inc<span style='letter-spacing:.05pt'>l</span>uant<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> t</span>hé<span style='letter-spacing:.05pt'>r</span>ap<span style='letter-spacing:.05pt'>i</span>es<span style='letter-spacing:.05pt'> </span>ad<span style='letter-spacing:.15pt'>j</span>u<span style='letter-spacing:-.15pt'>v</span>an<span style='letter-spacing:.05pt'>t</span>es,<span style='letter-spacing:.05pt'> </span>est<span style='letter-spacing:.05pt'> t</span>e<span style='letter-spacing:.05pt'>r</span><span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>né.</p>
<p class=AmmCorpsTexte>Les<span style='letter-spacing:.05pt'> </span>donn<span style='letter-spacing:-.05pt'>é</span>es<span style='letter-spacing:.05pt'> </span>de sécur<span style='letter-spacing:.05pt'>it</span>é<span style='letter-spacing: .05pt'> </span>conce<span style='letter-spacing:.05pt'>r</span>nant<span style='letter-spacing:.05pt'> l’</span>assoc<span style='letter-spacing:.05pt'>i</span>a<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>du<span style='letter-spacing:.05pt'> </span>chlorhydrate de raloxifène et<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span>es<span style='letter-spacing:.05pt'>tr</span>o<span style='letter-spacing:-.15pt'>g</span>ènes<span style='letter-spacing:.05pt'> </span>par<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>v</span>o<span style='letter-spacing:.05pt'>i</span>e<span style='letter-spacing:.05pt'> </span>s<span style='letter-spacing:-.1pt'>y</span>s<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>que é<span style='letter-spacing:.05pt'>t</span>ant<span style='letter-spacing:.05pt'> li</span><span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>it</span>ées,<span style='letter-spacing:.05pt'> </span>ce<span style='letter-spacing:.05pt'>tt</span>e<span style='letter-spacing:.05pt'> </span>assoc<span style='letter-spacing:.05pt'>i</span>a<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>n’est<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> r</span>eco<span style='letter-spacing:-.2pt'>mm</span>andée.</p>
<p class=AmmCorpsTexte>Le chlorhydrate de raloxifène n’est<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> </span>e<span style='letter-spacing:.05pt'>ffi</span>cace<span style='letter-spacing:.05pt'> </span>pour d<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>nuer<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>s<span style='letter-spacing:-.1pt'>y</span><span style='letter-spacing:-.2pt'>m</span>p<span style='letter-spacing:.05pt'>t</span>ô<span style='letter-spacing:-.2pt'>m</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>v</span>aso<span style='letter-spacing:-.2pt'>m</span>o<span style='letter-spacing:.05pt'>t</span>eurs<span style='letter-spacing:.05pt'> (</span>bouf<span style='letter-spacing:.05pt'>f</span>ées<span style='letter-spacing:.05pt'> </span>de cha<span style='letter-spacing:.05pt'>l</span>eur)<span style='letter-spacing: .05pt'> </span>ou<span style='letter-spacing:.05pt'> </span>les au<span style='letter-spacing:.05pt'>tr</span>es<span style='letter-spacing:.05pt'> </span>s<span style='letter-spacing:-.1pt'>y</span><span style='letter-spacing:-.2pt'>m</span>p<span style='letter-spacing:.05pt'>t</span>ô<span style='letter-spacing:-.2pt'>m</span>es<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>énop<span style='letter-spacing:-.05pt'>a</span>use<span style='letter-spacing:.05pt'> li</span>és<span style='letter-spacing:.05pt'> </span>à<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>ca<span style='letter-spacing:.05pt'>r</span>ence<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:-.05pt'> œ</span>s<span style='letter-spacing:.05pt'>tr</span>o<span style='letter-spacing:-.15pt'>g</span>ènes.</p>
<p class=AmmCorpsTexte>Ce médicament con<span style='letter-spacing:.05pt'>ti</span>ent<span style='letter-spacing:.05pt'> </span>du <span style='letter-spacing:.05pt'>l</span>ac<span style='letter-spacing:.05pt'>t</span>ose. Les<span style='letter-spacing:.05pt'> </span>pa<span style='letter-spacing:.05pt'>ti</span>en<span style='letter-spacing: .05pt'>t</span>s<span style='letter-spacing:.05pt'> </span>présen<span style='letter-spacing:.05pt'>t</span>ant<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span>ano<span style='letter-spacing:-.25pt'>m</span>a<span style='letter-spacing:.05pt'>li</span>es<span style='letter-spacing:.05pt'> </span>hé<span style='letter-spacing:.05pt'>r</span>éd<span style='letter-spacing:.05pt'>it</span>a<span style='letter-spacing:.05pt'>ir</span>es<span style='letter-spacing:.05pt'> r</span>a<span style='letter-spacing:.05pt'>r</span>es<span style='letter-spacing:.05pt'> </span>d’<span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>t</span>o<span style='letter-spacing:.05pt'>l</span>é<span style='letter-spacing:.05pt'>r</span>ance<span style='letter-spacing:.05pt'> </span>au <span style='letter-spacing:-.1pt'>g</span>a<span style='letter-spacing:.05pt'>l</span>ac<span style='letter-spacing:.05pt'>t</span>ose,<span style='letter-spacing:.05pt'> </span>de dé<span style='letter-spacing:.05pt'>fi</span>c<span style='letter-spacing:.05pt'>i</span>t<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>L</span>app<span style='letter-spacing:.05pt'> </span>lac<span style='letter-spacing:.05pt'>t</span>ase<span style='letter-spacing:.05pt'> </span>ou<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:-.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>l</span>absorp<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>du<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>g</span><span style='letter-spacing:.05pt'>l</span>ucose<span style='letter-spacing:-.3pt'>-</span><span style='letter-spacing:-.1pt'>g</span>a<span style='letter-spacing:.05pt'>l</span>ac<span style='letter-spacing:.05pt'>t</span>ose<span style='letter-spacing:.05pt'> </span>ne doi<span style='letter-spacing:-.1pt'>v</span>ent<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> </span>prendre ce<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>éd<span style='letter-spacing:.05pt'>i</span>ca<span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>.</p>
<p class="AmmAnnexeTitre2"><a name="RcpInteractions">4.5. Interactions avec d'autres médicaments et autres formes d'interactions</a></p>
<p class=AmmCorpsTexte>L<span style='letter-spacing:-.2pt'>'</span>ad<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>on s<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.2pt'>m</span>u<span style='letter-spacing:.05pt'>lt</span>anée<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:-.2pt'>’antiacide contenant</span><span style='letter-spacing:.05pt'> </span>du ca<span style='letter-spacing:.05pt'>r</span>bona<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> </span>ca<span style='letter-spacing:.05pt'>l</span>c<span style='letter-spacing:.05pt'>i</span>um<span style='letter-spacing:-.2pt'> </span>ou de<span style='letter-spacing:.05pt'> l</span><span style='letter-spacing:-.2pt'>'</span>h<span style='letter-spacing:-.1pt'>y</span>d<span style='letter-spacing:.05pt'>r</span>ox<span style='letter-spacing:-.1pt'>y</span>de<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:-.1pt'>g</span>nés<span style='letter-spacing:.05pt'>i</span>um<span style='letter-spacing:-.2pt'> </span>et<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:-.2pt'>'</span>a<span style='letter-spacing:.05pt'>l</span>u<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>i</span>um<span style='letter-spacing:-.2pt'> </span>n<span style='letter-spacing:-.2pt'>'</span>a<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:.05pt'>’i</span>nc<span style='letter-spacing:.05pt'>i</span>dence<span style='letter-spacing:.05pt'> </span>sur<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>b<span style='letter-spacing:.05pt'>i</span>od<span style='letter-spacing:.05pt'>i</span>spon<span style='letter-spacing:.05pt'>i</span>b<span style='letter-spacing:.05pt'>ilit</span>é<span style='letter-spacing:.05pt'> </span>du chlorhydrate de raloxifène.</p>
<p class=AmmCorpsTexte>La<span style='letter-spacing:.05pt'> </span>co<span style='letter-spacing:-.2pt'>-</span>ad<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>on de<span style='letter-spacing:.05pt'> </span>chlorhydrate de raloxifène<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>w</span>a<span style='letter-spacing:.05pt'>rf</span>a<span style='letter-spacing:.05pt'>ri</span>ne ne <span style='letter-spacing:-.2pt'>m</span>odi<span style='letter-spacing: .05pt'>fi</span>e<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>propr<span style='letter-spacing:.05pt'>i</span>é<span style='letter-spacing:.05pt'>t</span>és<span style='letter-spacing:.05pt'> </span>pha<span style='letter-spacing:.05pt'>r</span><span style='letter-spacing:-.2pt'>m</span>acoc<span style='letter-spacing:.05pt'>i</span>né<span style='letter-spacing:.05pt'>ti</span>ques de<span style='letter-spacing:.05pt'> </span>ces<span style='letter-spacing:.05pt'> </span>deux p<span style='letter-spacing:.05pt'>r</span>odu<span style='letter-spacing:.05pt'>it</span>s. <span style='letter-spacing:-.05pt'>C</span>ependan<span style='letter-spacing: .05pt'>t</span>, des<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>nu<span style='letter-spacing:.05pt'>ti</span>ons<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>odé<span style='letter-spacing:.05pt'>r</span>ées<span style='letter-spacing:.05pt'> </span>du <span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:-.2pt'>m</span>ps<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>r</span>o<span style='letter-spacing:.05pt'>t</span>h<span style='letter-spacing:.05pt'>r</span>o<span style='letter-spacing:-.2pt'>m</span>b<span style='letter-spacing:.05pt'>i</span>ne<span style='letter-spacing:.05pt'> </span>ont<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>é obse<span style='letter-spacing:.05pt'>r</span><span style='letter-spacing: -.1pt'>v</span>ées<span style='letter-spacing:.05pt'> </span>e<span style='letter-spacing:.05pt'>t</span>,<span style='letter-spacing:.05pt'> </span>dans <span style='letter-spacing:.05pt'>l’</span>é<span style='letter-spacing:-.1pt'>v</span>en<span style='letter-spacing:.05pt'>t</span>ua<span style='letter-spacing:.05pt'>lit</span>é<span style='letter-spacing:.05pt'> </span>d’une ad<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>s<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.2pt'>m</span>u<span style='letter-spacing:.05pt'>lt</span>anée<span style='letter-spacing:.05pt'> </span>du<span style='letter-spacing:.05pt'> </span>chlorhydrate de raloxifène a<span style='letter-spacing:-.1pt'>v</span>ec<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>w</span>a<span style='letter-spacing:.05pt'>rf</span>a<span style='letter-spacing:.05pt'>ri</span>ne ou d<span style='letter-spacing:-.2pt'>'</span>au<span style='letter-spacing:.05pt'>tr</span>es<span style='letter-spacing:.05pt'> </span>dé<span style='letter-spacing:.05pt'>ri</span><span style='letter-spacing:-.1pt'>v</span>és<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span>cou<span style='letter-spacing:-.25pt'>m</span>a<span style='letter-spacing:.05pt'>ri</span>ne,<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing:.05pt'> t</span>e<span style='letter-spacing:-.2pt'>m</span>ps de pro<span style='letter-spacing:.05pt'>t</span>hro<span style='letter-spacing: -.2pt'>m</span>b<span style='letter-spacing:.05pt'>i</span>ne de<span style='letter-spacing:-.1pt'>v</span><span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>sur<span style='letter-spacing:-.1pt'>v</span>e<span style='letter-spacing:.05pt'>ill</span>é.</p>
<p class=AmmCorpsTexte>Les<span style='letter-spacing:.05pt'> </span>e<span style='letter-spacing:.05pt'>ff</span>e<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:.05pt'> </span>sur<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing:.05pt'> t</span>e<span style='letter-spacing:-.2pt'>m</span>ps de pro<span style='letter-spacing:.05pt'>t</span>hro<span style='letter-spacing: -.2pt'>m</span>b<span style='letter-spacing:.05pt'>i</span>ne peu<span style='letter-spacing:-.15pt'>v</span>ent<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:-.1pt'>v</span>o<span style='letter-spacing:.05pt'>l</span>uer<span style='letter-spacing:.05pt'> </span>sur<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>l</span>us<span style='letter-spacing:.05pt'>i</span>eurs<span style='letter-spacing:.05pt'> </span>se<span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>i</span>nes<span style='letter-spacing:.05pt'> </span>si<span style='letter-spacing:.05pt'> </span>un<span style='letter-spacing:.05pt'> </span>t<span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>par le chlorhydrate de raloxifène est<span style='letter-spacing:.05pt'> </span>débuté<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> </span>pa<span style='letter-spacing:.05pt'>ti</span>en<span style='letter-spacing:.05pt'>t</span>es<span style='letter-spacing:.05pt'> </span>qui sont dé<span style='letter-spacing: .15pt'>j</span>à<span style='letter-spacing:.05pt'> </span>sous <span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>an<span style='letter-spacing:.05pt'>ti</span>coa<span style='letter-spacing:-.1pt'>g</span>u<span style='letter-spacing:.05pt'>l</span>ant<span style='letter-spacing:.05pt'> </span>cou<span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>ri</span>n<span style='letter-spacing:.05pt'>i</span>que.</p>
<p class=AmmCorpsTexte>Le chlorhydrate de raloxifène n’a<span style='letter-spacing: .05pt'> </span>pas<span style='letter-spacing:.05pt'> </span>d’e<span style='letter-spacing:.05pt'>ff</span>et<span style='letter-spacing:.05pt'> </span>sur<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>pha<span style='letter-spacing:.05pt'>r</span><span style='letter-spacing:-.2pt'>m</span>acoc<span style='letter-spacing:.05pt'>i</span>né<span style='letter-spacing:.05pt'>ti</span>que de <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing: .05pt'> </span><span style='letter-spacing:-.2pt'>m</span>é<span style='letter-spacing:.05pt'>t</span>h<span style='letter-spacing:-.15pt'>y</span><span style='letter-spacing:.05pt'>l</span>predniso<span style='letter-spacing:.05pt'>l</span>one ad<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>tr</span>ée<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'> </span>do<span style='letter-spacing:-.05pt'>s</span>e un<span style='letter-spacing:.05pt'>i</span>que.</p>
<p class=AmmCorpsTexte>Le chlorhydrate de raloxifène ne <span style='letter-spacing: -.2pt'>m</span>odi<span style='letter-spacing:.05pt'>fi</span>e<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> l</span><span style='letter-spacing:-.2pt'>'</span>a<span style='letter-spacing:.05pt'>ir</span>e<span style='letter-spacing:.05pt'> </span>sous <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span>courbe <span style='letter-spacing:.05pt'>(</span><span style='letter-spacing:-.05pt'>AUC</span>)<span style='letter-spacing:.05pt'> </span>à<span style='letter-spacing:.05pt'> l</span><span style='letter-spacing:-.2pt'>'</span>équi<span style='letter-spacing:.05pt'>li</span>bre<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing: -.1pt'>g</span>oxine.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>L</span>a<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.15pt'>C</span><sub><span style='font-size:7.0pt; letter-spacing:-.25pt'>m</span></sub><sub><span style='font-size:7.0pt; letter-spacing:.05pt'>a</span></sub><sub><span style='font-size:7.0pt'>x</span></sub><sub><span style='font-size:7.0pt;letter-spacing:.8pt'> </span></sub>de <span style='letter-spacing:.05pt'>l</span>a d<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>g</span>ox<span style='letter-spacing:.05pt'>i</span>ne<span style='letter-spacing:.05pt'> </span>au<span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>o<span style='letter-spacing:.05pt'>i</span>ns<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> </span>5 <span style='letter-spacing:.05pt'>%.</span></p>
<p class=AmmCorpsTexte>L<span style='letter-spacing:-.2pt'>'</span><span style='letter-spacing:.05pt'>i</span>nf<span style='letter-spacing:.05pt'>l</span>uence<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:.05pt'> </span>conco<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>it</span>an<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:.05pt'> </span>sur<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>concen<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>ons p<span style='letter-spacing:.05pt'>l</span>as<span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>ti</span>ques<span style='letter-spacing:.05pt'> </span>du<span style='letter-spacing:.05pt'> </span>chlorhydrate de raloxifène a<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>é é<span style='letter-spacing:-.1pt'>v</span>a<span style='letter-spacing:.05pt'>l</span>uée<span style='letter-spacing:.05pt'> </span>au<span style='letter-spacing:.05pt'> </span>cours<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span>essa<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'> </span>c<span style='letter-spacing:.05pt'>li</span>n<span style='letter-spacing:.05pt'>i</span>ques<span style='letter-spacing:.05pt'> </span>de pré<span style='letter-spacing:-.1pt'>v</span>en<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>l’</span>os<span style='letter-spacing:.05pt'>t</span>éoporose.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>L</span>es <span style='letter-spacing: -.2pt'>m</span>éd<span style='letter-spacing:.05pt'>i</span>ca<span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:.05pt'> fr</span>éque<span style='letter-spacing:-.2pt'>mm</span>ent<span style='letter-spacing:.05pt'> </span>c<span style='letter-spacing:-.05pt'>o</span><span style='letter-spacing:-.2pt'>-</span>ad<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>tr</span>és<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:.05pt'>i</span>ent :<span style='letter-spacing:.05pt'> </span>pa<span style='letter-spacing:.05pt'>r</span>acé<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:-.2pt'>m</span>o<span style='letter-spacing:.05pt'>l</span>,<span style='letter-spacing:.05pt'> </span>ant<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.2pt'>-</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>fl</span>a<span style='letter-spacing:-.2pt'>mm</span>a<span style='letter-spacing:.05pt'>t</span>o<span style='letter-spacing:.05pt'>ir</span>es<span style='letter-spacing:.05pt'> </span>non s<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'>r</span>o<span style='letter-spacing:.05pt'>ï</span>d<span style='letter-spacing:.05pt'>i</span>ens <span style='letter-spacing:.05pt'>(</span>co<span style='letter-spacing:-.2pt'>mm</span>e<span style='letter-spacing:.05pt'> l’</span>ac<span style='letter-spacing:.05pt'>i</span>de<span style='letter-spacing:.05pt'> </span>acé<span style='letter-spacing:.05pt'>t</span><span style='letter-spacing:-.1pt'>y</span><span style='letter-spacing:.05pt'>l</span>sa<span style='letter-spacing:.05pt'>li</span>c<span style='letter-spacing:-.1pt'>y</span><span style='letter-spacing:.05pt'>li</span>que, <span style='letter-spacing:.05pt'>l’i</span>bup<span style='letter-spacing:.05pt'>r</span>o<span style='letter-spacing:.05pt'>f</span>ène, et<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing: .05pt'> </span>nap<span style='letter-spacing:.05pt'>r</span>oxène<span style='letter-spacing:.05pt'>)</span>, an<span style='letter-spacing:.05pt'>ti</span>b<span style='letter-spacing:.05pt'>i</span>o<span style='letter-spacing:.05pt'>ti</span>ques<span style='letter-spacing:.05pt'> </span>o<span style='letter-spacing:.05pt'>r</span>aux, an<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:-.1pt'>g</span>on<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>t</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>H</span>1, an<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:-.1pt'>g</span>on<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>t</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>H</span>2 et<span style='letter-spacing:.05pt'> </span>ben<span style='letter-spacing: -.1pt'>z</span>od<span style='letter-spacing:.05pt'>i</span>a<span style='letter-spacing:-.1pt'>z</span>ép<span style='letter-spacing:.05pt'>i</span>nes. <span style='letter-spacing:-.05pt'>A</span>ucun e<span style='letter-spacing: .05pt'>ff</span>et<span style='letter-spacing:.05pt'> </span>c<span style='letter-spacing:.05pt'>li</span>n<span style='letter-spacing:.05pt'>i</span>que<span style='letter-spacing:.05pt'> </span>pe<span style='letter-spacing:.05pt'>rti</span>nent<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>co<span style='letter-spacing:-.3pt'>-</span>ad<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:-.05pt'> </span>ces subs<span style='letter-spacing:.05pt'>t</span>ances<span style='letter-spacing:.05pt'> </span>sur<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>concen<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>ons p<span style='letter-spacing:.05pt'>l</span>as<span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>ti</span>ques<span style='letter-spacing:.05pt'> </span>du chlorhydrate de raloxifène n’a<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'> i</span>den<span style='letter-spacing:.05pt'>tifi</span>é.</p>
<p class=AmmCorpsTexte>L<span style='letter-spacing:.05pt'>’u</span>t<span style='letter-spacing:.05pt'>ili</span>sa<span style='letter-spacing:.05pt'>tio</span>n<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>c</span><span style='letter-spacing:.05pt'>on</span><span style='letter-spacing:-.1pt'>c</span><span style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.25pt'>m</span><span style='letter-spacing:.05pt'>it</span>a<span style='letter-spacing:.05pt'>n</span>te<span style='letter-spacing:.05pt'> </span>d’<span style='letter-spacing:-.05pt'>œ</span>s<span style='letter-spacing:.05pt'>tr</span>o<span style='letter-spacing:-.15pt'>g</span>ènes<span style='letter-spacing:.05pt'> </span>par<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>v</span>o<span style='letter-spacing:.05pt'>i</span>e<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>v</span>a<span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>i</span>na<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'> </span>au<span style='letter-spacing:.05pt'>t</span>or<span style='letter-spacing:.05pt'>i</span>sée<span style='letter-spacing:.05pt'> </span>au<span style='letter-spacing:.05pt'> </span>cours<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span>essa<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'> </span>c<span style='letter-spacing:.05pt'>li</span>n<span style='letter-spacing:.05pt'>i</span>ques <span style='letter-spacing:.05pt'>l</span>orsqu’<span style='letter-spacing:.05pt'>i</span>l<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:.05pt'>i</span>t<span style='letter-spacing:.05pt'> </span>nécessa<span style='letter-spacing:.05pt'>ir</span>e<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>it</span>er<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span>s<span style='letter-spacing:-.1pt'>y</span><span style='letter-spacing:-.2pt'>m</span>p<span style='letter-spacing:.05pt'>t</span>ô<span style='letter-spacing:-.2pt'>m</span>es<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'> </span>rapport<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>v</span>ec<span style='letter-spacing: .05pt'> </span>une a<span style='letter-spacing:.05pt'>tr</span>ophie<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>v</span>a<span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>i</span>na<span style='letter-spacing:.05pt'>l</span>e.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>L</span>eur u<span style='letter-spacing:.05pt'>tili</span>sa<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>n’a<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>l</span>us <span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.2pt'>m</span>por<span style='letter-spacing:.05pt'>t</span>an<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> </span>pa<span style='letter-spacing:.05pt'>ti</span>en<span style='letter-spacing:.05pt'>t</span>es<span style='letter-spacing:.05pt'> tr</span>a<span style='letter-spacing:.05pt'>it</span>ées<span style='letter-spacing:.05pt'> </span>par<span style='letter-spacing:.05pt'> </span>le chlorhydrate de raloxifène que chez<span style='letter-spacing:-.1pt'> </span>ce<span style='letter-spacing:.05pt'>ll</span>es<span style='letter-spacing:.05pt'> </span>sous p<span style='letter-spacing:.05pt'>l</span>acebo.</p>
<p class=AmmCorpsTexte><i><span style='letter-spacing:.05pt'>I</span>n<span style='letter-spacing:.05pt'> </span>v<span style='letter-spacing:.05pt'>it</span>ro</i>, le chlorhydrate de raloxifène<span style='letter-spacing:.05pt'> </span>n<span style='letter-spacing:.05pt'>’i</span>n<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>i</span>t<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>v</span>ec<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> li</span>a<span style='letter-spacing:.05pt'>i</span>son p<span style='letter-spacing:.05pt'>r</span>o<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'>i</span>que<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>w</span>a<span style='letter-spacing:.05pt'>rf</span>a<span style='letter-spacing:.05pt'>ri</span>ne, de<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing: .05pt'> </span>phén<span style='letter-spacing:-.1pt'>y</span><span style='letter-spacing:.05pt'>t</span>o<span style='letter-spacing:.05pt'>ï</span>ne, ou du <span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing: -.2pt'>m</span>ox<span style='letter-spacing:.05pt'>if</span>ène.</p>
<p class=AmmCorpsTexte>Le chlorhydrate de raloxifène ne<span style='letter-spacing: .05pt'> </span>do<span style='letter-spacing:.05pt'>i</span>t pas<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>ad<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>tr</span>é<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'> </span>assoc<span style='letter-spacing:.05pt'>i</span>a<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>v</span>ec<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>choles<span style='letter-spacing:.05pt'>t</span><span style='letter-spacing:-.1pt'>y</span><span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>ne <span style='letter-spacing:.05pt'>(</span>ou<span style='letter-spacing:.05pt'> </span>au<span style='letter-spacing:.05pt'>tr</span>es<span style='letter-spacing: .05pt'> r</span>és<span style='letter-spacing:.05pt'>i</span>nes échan<span style='letter-spacing:-.15pt'>g</span>euses<span style='letter-spacing:.05pt'> </span>d’an<span style='letter-spacing:.05pt'>i</span>ons)<span style='letter-spacing:.05pt'> </span>qui <span style='letter-spacing:.05pt'>r</span>éduit<span style='letter-spacing: .05pt'> </span>s<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>g</span>n<span style='letter-spacing:.05pt'>ifi</span>ca<span style='letter-spacing:.05pt'>ti</span><span style='letter-spacing:-.1pt'>v</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> l</span><span style='letter-spacing:-.2pt'>'</span>absorp<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing:.05pt'> </span>c<span style='letter-spacing:-.1pt'>y</span>c<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'>r</span>ohépa<span style='letter-spacing:.05pt'>ti</span>que du chlorhydrate de raloxifène.</p>
<p class=AmmCorpsTexte>Les<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>i</span>cs<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> </span>concen<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>on du chlorhydrate de raloxifène<span style='letter-spacing:.05pt'> </span>sont<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>nués<span style='letter-spacing:.05pt'> </span>en cas<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing: -.2pt'>'</span>ad<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.05pt'>s</span><span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>on conco<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>it</span>an<span style='letter-spacing:.05pt'>t</span>e d<span style='letter-spacing:-.2pt'>'</span>a<span style='letter-spacing:-.2pt'>m</span>p<span style='letter-spacing:.05pt'>i</span>c<span style='letter-spacing:.05pt'>illi</span>ne. <span style='letter-spacing:-.05pt'>C</span>ependan<span style='letter-spacing: .05pt'>t</span>, é<span style='letter-spacing:.05pt'>t</span>ant<span style='letter-spacing:.05pt'> </span>donné<span style='letter-spacing:.05pt'> </span>que<span style='letter-spacing:.05pt'> l</span><span style='letter-spacing:-.2pt'>'</span>abso<span style='letter-spacing:.05pt'>r</span>p<span style='letter-spacing:.05pt'>ti</span>on et<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing: .05pt'> t</span>aux d<span style='letter-spacing:-.2pt'>'</span>é<span style='letter-spacing:.05pt'>li</span><span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>na<span style='letter-spacing:.05pt'>ti</span>on du chlorhydrate de raloxifène ne<span style='letter-spacing:.05pt'> </span>sont pas<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing: .05pt'>ff</span>ec<span style='letter-spacing:.05pt'>t</span>és,<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing:.05pt'> </span>chlorhydrate de raloxifène peut<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>ad<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>tr</span>é<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'> </span>assoc<span style='letter-spacing:.05pt'>i</span>a<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>v</span>ec<span style='letter-spacing:.05pt'> l</span><span style='letter-spacing:-.2pt'>'</span>a<span style='letter-spacing:-.2pt'>m</span>p<span style='letter-spacing:.05pt'>i</span>c<span style='letter-spacing:.05pt'>illi</span>ne.</p>
<p class=AmmCorpsTexte>Le<span style='letter-spacing:.05pt'> </span>chlorhydrate de raloxifène au<span style='letter-spacing:-.15pt'>g</span><span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>odé<span style='letter-spacing:.05pt'>r</span>é<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>concen<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:-.05pt'>t</span><span style='letter-spacing:.05pt'>i</span>ons<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>l</span>obu<span style='letter-spacing:.05pt'>li</span>nes<span style='letter-spacing:.05pt'> fi</span>xant<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>ho<span style='letter-spacing: .05pt'>r</span><span style='letter-spacing:-.2pt'>m</span>ones <span style='letter-spacing:.05pt'>(</span>“ho<span style='letter-spacing:.05pt'>r</span><span style='letter-spacing:-.2pt'>m</span>one<span style='letter-spacing:-.2pt'>-</span>b<span style='letter-spacing:.05pt'>i</span>nd<span style='letter-spacing:.05pt'>i</span>ng<span style='letter-spacing:-.1pt'> g</span><span style='letter-spacing:.05pt'>l</span>obu<span style='letter-spacing:.05pt'>li</span>ns”)<span style='letter-spacing:.05pt'> </span>y<span style='letter-spacing:-.1pt'> </span>co<span style='letter-spacing:-.2pt'>m</span>p<span style='letter-spacing:.05pt'>ri</span>s<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>l</span>obu<span style='letter-spacing:.05pt'>li</span>nes<span style='letter-spacing:.05pt'> fi</span>xant<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>ho<span style='letter-spacing: .05pt'>r</span><span style='letter-spacing:-.2pt'>m</span>ones<span style='letter-spacing:.05pt'> </span>sexue<span style='letter-spacing:.05pt'>ll</span>es<span style='letter-spacing:.05pt'> </span>“<span style='letter-spacing:-.05pt'> </span>sex ho<span style='letter-spacing:.05pt'>r</span><span style='letter-spacing:-.2pt'>m</span>one b<span style='letter-spacing:.05pt'>i</span>nd<span style='letter-spacing:.05pt'>i</span>ng<span style='letter-spacing:-.1pt'> g</span><span style='letter-spacing:.05pt'>l</span>obu<span style='letter-spacing:.05pt'>li</span>ns ”<span style='letter-spacing:.05pt'> (</span>S<span style='letter-spacing:-.05pt'>HBG</span><span style='letter-spacing:.05pt'>)</span>, <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing: .05pt'>l</span>obu<span style='letter-spacing:.05pt'>li</span>ne<span style='letter-spacing:.05pt'> fi</span>xant<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> t</span>h<span style='letter-spacing: -.1pt'>y</span><span style='letter-spacing:.05pt'>r</span>ox<span style='letter-spacing:.05pt'>i</span>ne<span style='letter-spacing:.05pt'> </span>“ <span style='letter-spacing:.05pt'>t</span>h<span style='letter-spacing:-.1pt'>y</span><span style='letter-spacing:.05pt'>r</span>ox<span style='letter-spacing:.05pt'>i</span>ne<span style='letter-spacing:.05pt'> </span>b<span style='letter-spacing:.05pt'>i</span>nd<span style='letter-spacing:.05pt'>i</span>ng<span style='letter-spacing:-.1pt'> g</span><span style='letter-spacing:.05pt'>l</span>obu<span style='letter-spacing:.05pt'>li</span>n ”<span style='letter-spacing:.05pt'> (</span><span style='letter-spacing:.1pt'>T</span><span style='letter-spacing:-.05pt'>BG</span>)<span style='letter-spacing:.05pt'> </span>et <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing: .05pt'>lobu</span><span style='letter-spacing:-.1pt'>l</span><span style='letter-spacing:.05pt'>in</span>e <span style='letter-spacing:.05pt'>fi</span><span style='letter-spacing:-.05pt'>x</span>ant<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>cor<span style='letter-spacing:.05pt'>ti</span>cos<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'>r</span>o<span style='letter-spacing:.05pt'>ï</span>des<span style='letter-spacing:.05pt'> </span>“<span style='letter-spacing:.05pt'> </span>co<span style='letter-spacing:.05pt'>rti</span>cos<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'>r</span>o<span style='letter-spacing:.05pt'>ï</span>d b<span style='letter-spacing:.05pt'>i</span>nd<span style='letter-spacing:.05pt'>i</span>ng<span style='letter-spacing:-.1pt'> g</span><span style='letter-spacing:.05pt'>l</span>obu<span style='letter-spacing:.05pt'>li</span>n ”<span style='letter-spacing:.05pt'> (</span><span style='letter-spacing:-.05pt'>CBG</span><span style='letter-spacing:.05pt'>)</span>,<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>v</span>ec<span style='letter-spacing:.05pt'> </span>une au<span style='letter-spacing:-.15pt'>g</span><span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>cor<span style='letter-spacing:.05pt'>r</span>espond<span style='letter-spacing:-.05pt'>a</span>n<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span>concen<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>ons hor<span style='letter-spacing:-.2pt'>m</span>ona<span style='letter-spacing: .05pt'>l</span>es<span style='letter-spacing:.05pt'> t</span>o<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:.05pt'>l</span>es.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>C</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>odi<span style='letter-spacing:.05pt'>fi</span>ca<span style='letter-spacing:.05pt'>ti</span>ons n’a<span style='letter-spacing:.05pt'>ff</span>ec<span style='letter-spacing: .05pt'>t</span>ent pas<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>concen<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>ons en<span style='letter-spacing:.05pt'> </span>hor<span style='letter-spacing:-.2pt'>m</span>ones<span style='letter-spacing:.05pt'> li</span>bres.</p>
<p class="AmmAnnexeTitre2"><a name="RcpGrossAllait">4.6. Grossesse et allaitement</a></p>
<p class=AmmAnnexeTitre2Bis><a name="_Toc142278926">Grossesse</a></p>
<p class=AmmCorpsTexte>Le chlorhydrate de raloxifène ne doit<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>u<span style='letter-spacing:.05pt'>tili</span>sé<span style='letter-spacing:.05pt'> </span>que chez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing: .05pt'> f</span>e<span style='letter-spacing:-.2pt'>mm</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>énop<span style='letter-spacing:-.05pt'>a</span>usées.</p>
<p class=AmmCorpsTexte>Le chlorhydrate de raloxifène ne doit<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>pr<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'> </span>par<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> f</span>e<span style='letter-spacing:-.2pt'>mm</span>es<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'> </span>â<span style='letter-spacing:-.1pt'>g</span>e<span style='letter-spacing:.05pt'> </span>de proc<span style='letter-spacing:.05pt'>r</span>ée<span style='letter-spacing:.05pt'>r</span>.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>L</span>e<span style='letter-spacing:.05pt'> </span>chlorhydrate de raloxifène peut<span style='letter-spacing:.05pt'> </span>pro<span style='letter-spacing:-.15pt'>v</span>oqu<span style='letter-spacing:-.05pt'>e</span>r<span style='letter-spacing:.05pt'> </span>des ano<span style='letter-spacing:-.25pt'>m</span>a<span style='letter-spacing:.05pt'>li</span>es<span style='letter-spacing:.05pt'> f</span><span style='letter-spacing:-.05pt'>œ</span><span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> </span>s<span style='letter-spacing:-.2pt'>'</span><span style='letter-spacing:.05pt'>i</span>l<span style='letter-spacing:.05pt'> </span>est<span style='letter-spacing:.05pt'> </span>ad<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>tr</span>é<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> f</span>e<span style='letter-spacing:-.2pt'>mm</span>e<span style='letter-spacing:.05pt'> </span>ence<span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>t</span>e.<span style='letter-spacing:.05pt'> </span></p>
<p class=AmmCorpsTexte><span style='letter-spacing:-.05pt'>S</span>i<span style='letter-spacing:.05pt'> </span>ce<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>éd<span style='letter-spacing:.05pt'>i</span>ca<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>est<span style='letter-spacing:.05pt'> </span>u<span style='letter-spacing:.05pt'>tili</span>sé<span style='letter-spacing:.05pt'> </span>par<span style='letter-spacing:.05pt'> </span>e<span style='letter-spacing:.05pt'>rr</span>eur pendant<span style='letter-spacing: .05pt'> l</span>a<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>r</span>ossesse,<span style='letter-spacing:.05pt'> </span>ou<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>s</span>i<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>pa<span style='letter-spacing:.05pt'>ti</span>en<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'> </span>débute<span style='letter-spacing:.05pt'> </span>une <span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>r</span>ossesse<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'>l</span>ors<span style='letter-spacing: .05pt'> </span>qu<span style='letter-spacing:-.25pt'>'</span>e<span style='letter-spacing:.05pt'>ll</span>e<span style='letter-spacing:.05pt'> </span>est<span style='letter-spacing:.05pt'> </span>sous <span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>,<span style='letter-spacing:.05pt'> </span>e<span style='letter-spacing:.05pt'>ll</span>e<span style='letter-spacing:.05pt'> </span>doit ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> i</span>nfor<span style='letter-spacing:-.2pt'>m</span>ée<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> ri</span>sques<span style='letter-spacing:.05pt'> </span>poten<span style='letter-spacing:.05pt'>ti</span>e<span style='letter-spacing:.05pt'>l</span>s<span style='letter-spacing:.05pt'> </span>pour <span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> f</span><span style='letter-spacing:-.05pt'>œ</span><span style='letter-spacing: .05pt'>t</span><span style='letter-spacing:-.05pt'>u</span>s<span style='letter-spacing:.1pt'> </span>(<span style='letter-spacing:-.1pt'>vo</span><span style='letter-spacing:.2pt'>i</span>r<span style='letter-spacing:.05pt'> r</span>ub<span style='letter-spacing:.05pt'>ri</span>que<span style='letter-spacing:.05pt'> </span>5.3.<span style='letter-spacing:.05pt'>)</span>.</p>
<p class=AmmAnnexeTitre2Bis><a name="_Toc142278927">Allaitement</a></p>
<p class=AmmCorpsTexte>L<span style='letter-spacing: .05pt'>’</span>exc<span style='letter-spacing:.05pt'>r</span>é<span style='letter-spacing:.05pt'>ti</span>on du chlorhydrate de raloxifène<span style='letter-spacing:.05pt'> /</span>des<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>é<span style='letter-spacing:.05pt'>t</span>abol<span style='letter-spacing:.05pt'>it</span>es<span style='letter-spacing:.05pt'> </span>du<span style='letter-spacing:-.05pt'> </span>chlorhydrate de raloxifène dans <span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'>i</span>t<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'>r</span>nel<span style='letter-spacing:.05pt'> </span>n’est<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> </span>connu<span style='letter-spacing:-.05pt'>e</span>.<span style='letter-spacing:-.05pt'> Un </span><span style='letter-spacing:.05pt'>ri</span>sque<span style='letter-spacing:.05pt'> </span>pour<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>nou<span style='letter-spacing:-.1pt'>v</span>eau<span style='letter-spacing:-.2pt'>-</span>nés<span style='letter-spacing:.05pt'>/</span>nou<span style='letter-spacing:.05pt'>rri</span>ssons<span style='letter-spacing:.05pt'> </span>ne<span style='letter-spacing:.05pt'> </span>peut<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> </span>ê<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing:.05pt'> </span>exc<span style='letter-spacing:.05pt'>l</span>u. Son u<span style='letter-spacing:.05pt'>tili</span>sa<span style='letter-spacing:.05pt'>ti</span>on n<span style='letter-spacing:.05pt'>’</span>est<span style='letter-spacing:.05pt'> </span>donc<span style='letter-spacing:.05pt'> </span>pas <span style='letter-spacing:.05pt'>r</span>eco<span style='letter-spacing:-.2pt'>mm</span>andée<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> f</span>e<span style='letter-spacing:-.2pt'>mm</span>es<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'>ll</span>a<span style='letter-spacing:.05pt'>it</span>an<span style='letter-spacing:.05pt'>t</span>es.<span style='letter-spacing:-.05pt'> Le </span>chlorhydrate de raloxifène pou<span style='letter-spacing:.05pt'>rr</span>a<span style='letter-spacing:.05pt'>i</span>t<span style='letter-spacing:.05pt'> </span>pe<span style='letter-spacing:.05pt'>rt</span>u<span style='letter-spacing:.05pt'>r</span>ber<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing:.05pt'> </span>dé<span style='letter-spacing:-.1pt'>v</span>e<span style='letter-spacing:.05pt'>l</span>oppe<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>du nou<span style='letter-spacing:-.1pt'>v</span>eau<span style='letter-spacing: -.3pt'>-</span>né.</p>
<p class="AmmAnnexeTitre2"><a name="RcpConduite">4.7. Effets sur l'aptitude à conduire des véhicules et à utiliser des machines</a></p>
<p class=AmmCorpsTexte>Le chlorhydrate de raloxifène n’a aucun effet ou qu’un effet négligeable sur l’aptitude à conduire des véhicules et à utiliser des machines.</p>
<p class="AmmAnnexeTitre2"><a name="RcpEffetsIndesirables">4.8. Effets indésirables</a></p>
<p class=AmmCorpsTexte>Dans les essais de traitement et de prévention de l’ostéoporose, impliquant plus de 13000 femmes ménopausées, tous les évènements indésirables ont été enregistrés. La durée du traitement dans ces essais se situait entre 6 et 60 mois. La majorité des évènements indésirables n’a habituellement pas nécessité d’arrêt de traitement.</p>
<p class=AmmCorpsTexte>Dans les essais de prévention, les arrêts de traitement dus à un évènement indésirable ont concerné 10,7 % des 581 patientes traitées par le chlorhydrate de raloxifène et 11,1 % des 584 patientes sous placebo. Dans les essais de traitement, les arrêts thérapeutiques dus à un évènement indésirable ont concerné 12,8 % des 2557 patientes traitées par le chlorhydrate de raloxifène et 11,1 % des 2576 patientes sous placebo.</p>
<p class=AmmCorpsTexte>Les évènements indésirables associés au traitement par le chlorhydrate de raloxifène au cours des études cliniques dans l’ostéoporose sont résumés dans le tableau ci-dessous.</p>
<p class=AmmCorpsTexte>Les effets indésirables ont été classés selon la convention suivante : très fréquents (&#8805;1/10), fréquents (&#8805;1 /100, &lt;1/10), peu fréquents (&#8805;1/1000, &lt;1/100), rares (&#8805;1/10 000, &lt; 1/1000), très rares (&lt;1/ 10 000), fréquence indéterminée (ne peut être estimée sur la base des données disponibles).</p>
<table class=AmmCorpsTexteTable border=1 cellspacing=0 cellpadding=0
style='border-collapse:collapse;border:none'>
<tr>
<td width=667 valign=top style='width:500.2pt;border:solid windowtext 1.0pt;
padding:0cm 5.4pt 0cm 5.4pt'>
<p class=AmmAnnexeTitre3>Affections vasculaires</p>
<p class=AmmCorpsTexte><i>Très fréquents</i> : Vasodilatation (bouffées de chaleur).</p>
<p class=AmmCorpsTexte><i>Peu fréquents</i> : Accidents thrombo-emboliques veineux, comprenant des thromboses veineuses profondes, des embolies pulmonaires, des thromboses veineuses rétiniennes. Thrombophlébites veineuses superficielles.</p>
</td>
</tr>
<tr>
<td width=667 valign=top style='width:500.2pt;border:solid windowtext 1.0pt;
border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class=AmmAnnexeTitre3>Affections musculo-squelettiques et systémiques</p>
<p class=AmmCorpsTexte><i>Fréquents</i> : Crampes dans les jambes</p>
</td>
</tr>
<tr>
<td width=667 valign=top style='width:500.2pt;border:solid windowtext 1.0pt;
border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class=AmmAnnexeTitre3>Troubles généraux et anomalies au site d’administration</p>
<p class=AmmCorpsTexte><i>Très fréquents</i> : Syndrome grippal</p>
<p class=AmmCorpsTexte><i>Fréquents </i>: OEdème périphérique</p>
</td>
</tr>
</table>
<p class=AmmCorpsTexte style='margin-top:6.0pt'>Comparé au groupe placebo, la survenue de vasodilatations (bouffées de chaleur) était modérément augmentée chez les patientes sous le chlorhydrate de chlorhydrate de raloxifène (dans les essais cliniques de prévention de l’ostéoporose, avec une ancienneté de ménopause située entre 2 et 8 ans, 24,3 % pour le chlorhydrate de raloxifène et 18,2 % pour le placebo; dans les essais cliniques de traitement de l’ostéoporose, avec une moyenne d’âge de 66 ans, 10,6 % pour le chlorhydrate de raloxifène et 7,1 % pour le placebo). Cet évènement indésirable était plus fréquent au cours des six premiers mois de traitement et survenait rarement de novo après cette période.</p>
<p class=AmmCorpsTexte>Dans une étude conduite chez 10 101 femmes ménopausées ayant une maladie coronarienne connue ou un risque accru d’accidents coronariens (étude RUTH), des symptômes vasomoteurs (bouffées de chaleur) sont survenues chez 7,8% des patientes traitées par le chlorhydrate de raloxifène et chez 4,7% des patientes traitées par le placebo.</p>
<p class=AmmCorpsTexte>Dans tous les essais cliniques contrôlés versus placebo de traitement de l’ostéoporose par le chlorhydrate de raloxifène, des accidents thrombo-emboliques veineux, comprenant des thromboses veineuses profondes, des embolies pulmonaires et des thromboses veineuses rétiniennes, sont survenus avec une fréquence d’environ 0,8 % soit 3,22 cas pour 1000 patientes-année. Un risque relatif de 1,60 (IC : 0,95-2,71) a été observé pour les patientes traitées par le chlorhydrate de raloxifène par rapport au placebo. </p>
<p class=AmmCorpsTexte>Le risque d’accidents thrombo-emboliques était plus important au cours des quatre premiers mois de traitement. Des thrombophlébites veineuses superficielles sont survenues avec une fréquence inférieure à 1 %.</p>
<p class=AmmCorpsTexte>Dans l’étude RUTH, les accidents thrombo-emboliques veineux sont survenus avec une fréquence approximative de 2,0% soit 3,88 cas pour 1000 patientes-année dans le groupe du chlorhydrate de raloxifène et une fréquence de 1,4% soit 2,70 cas pour 1000 patientes-année dans le groupe placebo. Dans l’étude RUTH, le risque relatif de survenue de l’ensemble des accidents thrombo-emboliques veineux était RR = 1,44, [1,06 – 1,95]. Les thrombophlébites veineuses superficielles sont survenues à une fréquence de 1% dans le groupe chlorhydrate de raloxifène et de 0,6% dans le groupe placebo.</p>
<p class=AmmCorpsTexte>Un autre évènement indésirable a été observé : il s’agit de crampes dans les jambes (5,5 % pour le chlorhydrate de raloxifène, 1,9 % pour le placebo dans la population incluse dans les essais de prévention et 9,2 % pour le chlorhydrate de raloxifène, 6,0 % pour le placebo dans la population incluse dans les essais de traitement).</p>
<p class=AmmCorpsTexte>Dans l’étude RUTH, des crampes dans les jambes ont été observées chez 12,1% des patientes traitées par le chlorhydrate de raloxifène et 8,3% des patientes traitées par le placebo.</p>
<p class=AmmCorpsTexte>Un syndrome grippal a été rapporté par 16,2 % des patientes traitées par le chlorhydrate de raloxifène et 14,0 % des patientes sous placebo.</p>
<p class=AmmCorpsTexte>Un effet a également été observé et considéré comme non statistiquement significatif (p &gt; 0,05), mais nettement dose-dépendant. Il s’agit d’un œdème périphérique, qui apparaissait dans la population incluse dans les essais de prévention avec une incidence de 3,1 % sous le chlorhydrate de raloxifène et 1,9 % sous placebo et dans la population incluse dans les essais de traitement avec une incidence de 7,1 % sous le chlorhydrate de raloxifène et de 6,1 % sous placebo.</p>
<p class=AmmCorpsTexte>Dans l’étude RUTH, un œdème périphérique est survenu chez 14,1% des patientes traitées par le chlorhydrate de raloxifène et chez 11,7% des patientes traitées par le placebo, avec une différence statistiquement significative.</p>
<p class=AmmCorpsTexte>Une faible diminution du nombre de plaquettes (6-10 %) a été rapportée sous chlorhydrate de raloxifène dans les essais cliniques contrôlés versus placebo, conduits avec le chlorhydrate de raloxifène dans l’ostéoporose.</p>
<p class=AmmCorpsTexte>De rares cas d’augmentation modérée des ASAT et/ou des ALAT ont été rapportés sans que puisse être exclue une relation de causalité avec le chlorhydrate de raloxifène. Ces augmentations ont été observées avec une fréquence identique chez les patientes sous placebo.</p>
<p class=AmmCorpsTexte><u>Dans une étude (RUTH)</u> conduite chez des femmes ménopausées ayant une maladie coronarienne connue ou un risque accru d’accidents coronariens, un autre effet indésirable, la lithiase biliaire, est survenu chez 3,3% des patientes traitées par le chlorhydrate de raloxifène et chez 2,6% des patientes traitées par le placebo. Les taux de cholécystectomie n’étaient pas statistiquement significativement différents entre le groupe chlorhydrate de raloxifène (2,3%) et le groupe placebo (2,0%).</p>
<p class=AmmCorpsTexte>Des essais cliniques ont comparé le chlorhydrate de raloxifène (n=317) à un traitement hormonal substitutif (THS) combiné continu (n=110) ou cyclique (n=205). L’incidence des symptômes mammaires et des saignements d’origine utérine était significativement inférieure chez les patientes sous chlorhydrate de raloxifène par rapport aux patientes sous traitement hormonal substitutif, quel qu’il soit.</p>
<p class=AmmCorpsTexte>Les événements indésirables rapportés depuis la commercialisation sont présentés dans le tableau ci-dessous.</p>
<table class=AmmCorpsTexteTable border=1 cellspacing=0 cellpadding=0
style='border-collapse:collapse;border:none'>
<tr>
<td width=667 valign=top style='width:500.2pt;border:solid windowtext 1.0pt;
padding:0cm 5.4pt 0cm 5.4pt'>
<p class=AmmAnnexeTitre3 style='page-break-after:auto'>Affections hématologiques et du système lymphatique</p>
<p class=AmmCorpsTexte>Très rares : thrombocytopénie</p>
</td>
</tr>
<tr>
<td width=667 valign=top style='width:500.2pt;border:solid windowtext 1.0pt;
border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class=AmmAnnexeTitre3 style='page-break-after:auto'>Affections gastro-intestinales</p>
<p class=AmmCorpsTexte>Très rares : Symptômes gastro-intestinaux tels que nausées, vomissements, douleurs abdominales et dyspepsie</p>
</td>
</tr>
<tr>
<td width=667 valign=top style='width:500.2pt;border:solid windowtext 1.0pt;
border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class=AmmAnnexeTitre3 style='page-break-after:auto'>Troubles généraux et anomalies au site d’administration</p>
<p class=AmmCorpsTexte>Rares : oedème périphérique</p>
</td>
</tr>
<tr>
<td width=667 valign=top style='width:500.2pt;border:solid windowtext 1.0pt;
border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class=AmmAnnexeTitre3 style='page-break-after:auto'>Investigations</p>
<p class=AmmCorpsTexte>Très rares : Augmentation de la pression artérielle</p>
</td>
</tr>
<tr>
<td width=667 valign=top style='width:500.2pt;border:solid windowtext 1.0pt;
border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class=AmmAnnexeTitre3 style='page-break-after:auto'>Affections du système nerveux</p>
<p class=AmmCorpsTexte>Très rares : Céphalées incluant la migraine</p>
</td>
</tr>
<tr>
<td width=667 valign=top style='width:500.2pt;border:solid windowtext 1.0pt;
border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class=AmmAnnexeTitre3 style='page-break-after:auto'>Affections de la peau et du tissu sous-cutané</p>
<p class=AmmCorpsTexte>Très rares : Rash cutané</p>
</td>
</tr>
<tr>
<td width=667 valign=top style='width:500.2pt;border:solid windowtext 1.0pt;
border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class=AmmAnnexeTitre3 style='page-break-after:auto'>Affections des organes de reproduction et du sein</p>
<p class=AmmCorpsTexte>Très rares : Symptômes mammaires légers tels que douleur, gonflement et tension mammaire</p>
</td>
</tr>
<tr>
<td width=667 valign=top style='width:500.2pt;border:solid windowtext 1.0pt;
border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class=AmmAnnexeTitre3>Affections vasculaires</p>
<p class=AmmCorpsTexte>Rares : réaction thromboembolique veineuse</p>
<p class=AmmCorpsTexte>Très rares : réaction thromboembolique artérielle</p>
</td>
</tr>
</table>
<p class=AmmAnnexeTitre3><a name="_Toc142278930">Déclaration des effets indésirables suspectés </a></p>
<p class=AmmCorpsTexte>La déclaration des effets indésirables suspectés après autorisation du médicament est importante. Elle permet une surveillance continue du rapport bénéfice/risque du médicament. Les professionnels de santé déclarent tout effet indésirable suspecté via le système national de déclaration : Agence nationale de sécurité du médicament et des produits de santé (Ansm) et réseau des Centres Régionaux de Pharmacovigilance - Site internet: <a href="http://www.ansm.sante.fr"><span style='color:windowtext; text-decoration:none'>www.ansm.sante.fr</span></a>.</p>
<p class="AmmAnnexeTitre2"><a name="RcpSurdosage">4.9. Surdosage</a></p>
<p class=AmmCorpsTexte><span style='letter-spacing:-.05pt'>D</span>ans ce<span style='letter-spacing:.05pt'>rt</span>a<span style='letter-spacing:.05pt'>i</span>ns essa<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing: .05pt'> </span>c<span style='letter-spacing:.05pt'>li</span>n<span style='letter-spacing:.05pt'>i</span>ques,<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span>doses<span style='letter-spacing:.05pt'> </span>quot<span style='letter-spacing:.05pt'>i</span>d<span style='letter-spacing:.05pt'>i</span>ennes<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'>ll</span>ant<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:.15pt'>j</span>usqu<span style='letter-spacing:.05pt'>’</span>à<span style='letter-spacing:.05pt'> </span>600 <span style='letter-spacing:-.2pt'>m</span>g<span style='letter-spacing:-.1pt'> </span>pendant<span style='letter-spacing:.05pt'> </span>8 se<span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>i</span>nes<span style='letter-spacing:.05pt'> </span>et 120 <span style='letter-spacing:-.2pt'>m</span>g<span style='letter-spacing:-.1pt'> </span>pendant<span style='letter-spacing:.05pt'> </span>3 ans ont é<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'> </span>ad<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>tr</span>ées. <span style='letter-spacing:-.05pt'>A</span>ucun<span style='letter-spacing:.05pt'> </span>cas<span style='letter-spacing:.05pt'> </span>de surdosa<span style='letter-spacing:-.1pt'>g</span>e<span style='letter-spacing: .05pt'> </span>a<span style='letter-spacing:-.1pt'>v</span>ec<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing:.05pt'> r</span>a<span style='letter-spacing:.05pt'>l</span>oxi<span style='letter-spacing:.05pt'>f</span>ène n’a<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing: .05pt'>t</span>é<span style='letter-spacing:.05pt'> r</span>epor<span style='letter-spacing:.05pt'>t</span>é durant<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>essa<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'> </span>c<span style='letter-spacing:.05pt'>li</span>n<span style='letter-spacing:.05pt'>i</span>ques.</p>
<p class=AmmCorpsTexte><span style='letter-spacing:-.05pt'>C</span>hez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l’</span>adul<span style='letter-spacing:.05pt'>t</span>e,<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span>c<span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:-.2pt'>m</span>pes<span style='letter-spacing:.05pt'> </span>dans <span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:.15pt'>j</span>a<span style='letter-spacing: -.2pt'>m</span>bes<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span>sensa<span style='letter-spacing:.05pt'>ti</span>ons <span style='letter-spacing:-.1pt'>v</span>e<span style='letter-spacing:.05pt'>rti</span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>i</span>neuses<span style='letter-spacing:.05pt'> </span>ont é<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'> r</span>appor<span style='letter-spacing:.05pt'>t</span>ées<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l</span>es pa<span style='letter-spacing:.05pt'>ti</span>en<span style='letter-spacing:.05pt'>t</span>es<span style='letter-spacing:.05pt'> </span>qui<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:-.1pt'>v</span>a<span style='letter-spacing:.05pt'>i</span>ent<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>ri</span>s<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>l</span>us<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> </span>120 <span style='letter-spacing:-.2pt'>m</span>g<span style='letter-spacing:-.1pt'> </span>en une<span style='letter-spacing:.05pt'> </span>seu<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>ri</span>se.</p>
<p class=AmmCorpsTexte>Lors<span style='letter-spacing:.05pt'> </span>de pr<span style='letter-spacing:.05pt'>i</span>ses<span style='letter-spacing:.05pt'> </span>acc<span style='letter-spacing:.05pt'>i</span>den<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'>ll</span>es<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing:-.1pt'> </span>des<span style='letter-spacing:.05pt'> </span>enfan<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:.05pt'> </span>â<span style='letter-spacing:-.1pt'>g</span>és<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:-.2pt'>m</span>o<span style='letter-spacing:.05pt'>i</span>ns de deux<span style='letter-spacing:.05pt'> </span>ans,<span style='letter-spacing: .05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>dose<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>ax<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> r</span>appor<span style='letter-spacing:.05pt'>t</span>ée<span style='letter-spacing:.05pt'> </span>a é<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'> </span>de 180<span style='letter-spacing:.05pt'> </span><span style='letter-spacing: -.25pt'>m</span><span style='letter-spacing:-.1pt'>g</span>.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>C</span>hez<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> </span>enfan<span style='letter-spacing:.05pt'>t</span>s,<span style='letter-spacing:.05pt'> l</span>es<span style='letter-spacing:.05pt'> </span>s<span style='letter-spacing:-.1pt'>y</span><span style='letter-spacing:-.2pt'>m</span>p<span style='letter-spacing:.05pt'>t</span>ô<span style='letter-spacing:-.2pt'>m</span>es<span style='letter-spacing:.05pt'> i</span>nc<span style='letter-spacing:.05pt'>l</span>ua<span style='letter-spacing:.05pt'>i</span>ent<span style='letter-spacing:.05pt'> </span>:<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'>t</span>ax<span style='letter-spacing:.05pt'>i</span>e,<span style='letter-spacing:.05pt'> </span>sensa<span style='letter-spacing:.05pt'>ti</span>ons <span style='letter-spacing:-.1pt'>v</span>e<span style='letter-spacing:.05pt'>rti</span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>i</span>neuses, <span style='letter-spacing:-.1pt'>v</span><span style='letter-spacing:-.2pt'>o</span>m<span style='letter-spacing:.05pt'>i</span>sse<span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>s,<span style='letter-spacing:.05pt'> </span>rashs cu<span style='letter-spacing:.05pt'>t</span>anés,<span style='letter-spacing:.05pt'> </span>dia<span style='letter-spacing:.05pt'>rr</span>hées,<span style='letter-spacing:.05pt'> tr</span>e<span style='letter-spacing:-.2pt'>m</span>b<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>s,<span style='letter-spacing:.05pt'> </span>bou<span style='letter-spacing:-.05pt'>f</span><span style='letter-spacing:.05pt'>f</span>ées<span style='letter-spacing:.05pt'> </span>de cha<span style='letter-spacing:.05pt'>l</span>eur<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>l</span>é<span style='letter-spacing:-.1pt'>v</span>a<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:-.05pt'>e</span>s pho<span style='letter-spacing:-.05pt'>s</span>pha<span style='letter-spacing:.05pt'>t</span>ases<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'>l</span>ca<span style='letter-spacing:.05pt'>li</span>nes.</p>
<p class=AmmCorpsTexte>Le<span style='letter-spacing:.05pt'> </span>surdosa<span style='letter-spacing:-.1pt'>g</span>e<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>l</span>us é<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:-.1pt'>v</span>é<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'> </span>approxi<span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>ti</span><span style='letter-spacing:-.1pt'>v</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>de 1,5<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>g</span><span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:-.2pt'>mm</span>e.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>A</span>ucun<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:-.05pt'>é</span>cès<span style='letter-spacing:.05pt'> </span>assoc<span style='letter-spacing:.05pt'>i</span>é<span style='letter-spacing:.05pt'> </span>à<span style='letter-spacing:.05pt'> </span>un surdosa<span style='letter-spacing:-.1pt'>g</span>e<span style='letter-spacing: .05pt'> </span>n’a<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'> r</span>appor<span style='letter-spacing:.05pt'>t</span>é.</p>
<p class=AmmCorpsTexte><span style='letter-spacing:-.2pt'>I</span>l<span style='letter-spacing:.05pt'> </span>n<span style='letter-spacing:.05pt'>’</span>ex<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'> </span>pas<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:.05pt'>’</span>an<span style='letter-spacing:.05pt'>ti</span>do<span style='letter-spacing:.05pt'>t</span>e spéc<span style='letter-spacing:.05pt'>ifi</span>que<span style='letter-spacing:.05pt'> </span>au ch<span style='letter-spacing:.05pt'>l</span>o<span style='letter-spacing:.05pt'>r</span>h<span style='letter-spacing:-.1pt'>y</span>d<span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> r</span>a<span style='letter-spacing:.05pt'>l</span>ox<span style='letter-spacing:.05pt'>if</span>ène.</p>
<p class="AmmAnnexeTitre1"><a name="RcpPropPharmacologie">5. PROPRIETES PHARMACOLOGIQUES</a></p>
<p class="AmmAnnexeTitre2"><a name="RcpPropPharmacodynamie">5.1. Propriétés pharmacodynamiques</a></p>
<p class=AmmCorpsTexteGras>Groupe pharmaco-thérapeutique: Modulateur Sélectif de l’Activation des Récepteurs aux</p>
<p class=AmmCorpsTexteGras>Oestrogènes. Code ATC: G03XC01.</p>
<p class=AmmAnnexeTitre3>Mécanisme d’action et effets pharmacodynamiques </p>
<p class=AmmCorpsTexte>En tant que modulateur sélectif de l’activation des récepteurs aux œstrogènes (MoSARE/SERM), le raloxifène possède des activités agonistes ou antagonistes sélectives sur les tissus sensibles aux œstrogènes. Il agit comme un agoniste sur l'os, partiellement sur le métabolisme du cholestérol (réduction du cholestérol total et du LDL-cholestérol), mais pas sur l’hypothalamus ou l'utérus ou le sein.</p>
<p class=AmmCorpsTexte>Les effets biologiques du raloxifène, comme ceux des œstrogènes, résultent d’une liaison de haute affinité aux récepteurs aux œstrogènes et d’une régulation de l’expression génique. Cette liaison entraîne des expressions différentes des nombreux gènes régulés par les œstrogènes dans différents tissus. Des données suggèrent que le récepteur aux œstrogènes peut réguler l'expression génique par au moins deux voies distinctes qui sont spécifiques au ligand, au tissu et/ou au gène.</p>
<p class=AmmCorpsTexteGras>a) Effets sur le squelette</p>
<p class=AmmCorpsTexte>La diminution des taux d’œstrogènes qui se produit au moment de la ménopause, entraîne une nette augmentation de la résorption osseuse, de la perte osseuse et du risque de fracture. La perte osseuse est particulièrement rapide pendant les dix premières années suivant la ménopause, lorsque l'augmentation compensatoire de la formation osseuse est inadaptée pour contrebalancer les pertes dues à la résorption. Les autres facteurs de risque pouvant entraîner le développement de l’ostéoporose incluent : une ménopause précoce; une ostéopénie (au moins 1 DS sous le pic de masse osseuse); un squelette de fine constitution; une origine ethnique caucasienne ou asiatique; des antécédents familiaux d’ostéoporose. Les traitements hormonaux substitutifs inhibent, de manière générale, la résorption osseuse excessive. Chez les femmes ménopausées ostéoporotiques, le chlorhydrate de raloxifène réduit l’incidence des fractures vertébrales, préserve la masse osseuse et augmente la Densité Minérale Osseuse (DMO).</p>
<p class=AmmCorpsTexte>Sur la base de ces facteurs de risque, la prévention de l’ostéoporose par chlorhydrate de raloxifène est indiquée pour les femmes ménopausées depuis moins de 10 ans avec une DMO au rachis comprise entre 1,0 et 2,5 DS en dessous de la valeur moyenne de la population normale jeune, en prenant en compte le risque élevé de fractures ostéoporotiques chez ces femmes à ce stade de leur vie. De la même façon, le chlorhydrate de raloxifène est indiqué pour le traitement de l’ostéoporose ou de l’ostéoporose avérée chez les femmes avec une DMO au rachis de 2,5 DS en dessous de la valeur moyenne de la population normale jeune et/ou avec des fractures vertébrales, quelle que soit la DMO.</p>
<p class=AmmCorpsTexte>i) Incidence des fractures. </p>
<p class=AmmCorpsTexte>Dans une étude conduite chez 7705 femmes ménopausées âgées en moyenne de 66 ans et ayant une ostéoporose ou une ostéoporose avec un antécédent de fracture, l’administration du chlorhydrate de raloxifène pendant 3 ans a réduit respectivement l’incidence des fractures vertébrales de 47 % (Risque Relatif (RR) = 0,53, Intervalle de Confiance (IC) : 0,35-0,79 ; p &lt; 0,001) et de 31 % (RR=0,69, IC : 0,56–0,86; p &lt; 0,001). Quarante-cinq femmes ostéoporotiques ou 15 femmes ostéoporotiques avec un antécédent fracturaire devront être traitées par chlorhydrate de raloxifène pendant 3 ans pour prévenir une ou plusieurs fractures vertébrales. Le traitement par chlorhydrate de raloxifène pendant 4 ans a réduit l’incidence des fractures vertébrales respectivement de 46 % (RR = 0,54 ; IC : 0,38-0,75) et de 32 % (RR = 0,68 ; IC : 0,56-0,83) chez les patientes ostéoporotiques ou ostéoporotiques avec un antécédent de fracture. Au cours de la quatrième année, le chlorhydrate de raloxifène a réduit le risque de nouvelle fracture vertébrale de 39% (RR = 0,61 ; IC : 0,43-0,88). Un effet sur les fractures non vertébrales n’a pas été démontré. De la 4ème à la 8ème année, les patientes ont été autorisées à recevoir un traitement concomitant de type bisphosphonate ou calcitonine ou fluor et toutes les patientes incluses dans cette étude ont reçu une supplémentation en calcium et vitamine D.</p>
<p class=AmmCorpsTexte>Dans l’étude RUTH, l’ensemble des fractures cliniques ont été recueillies en tant que critère secondaire. Le chlorhydrate de raloxifène a réduit l’incidence des fractures vertébrales cliniques de 35% comparé au placebo (Hazard Ratio 0,65, IC : 0,47-0,89). Ces résultats peuvent avoir été influencés, à l’inclusion, par des différences de Densité Minérale Osseuse et de fractures vertébrales. L’incidence des nouvelles fractures non vertébrales n’était pas différente entre les groupes de traitement. Durant toute la durée de l’étude, l’utilisation d’un autre traitement anti-ostéoporotique était autorisée.</p>
<p class=AmmCorpsTexte>ii) Densité Minérale Osseuse (DMO). L'efficacité du chlorhydrate de raloxifène en prise quotidienne a été établie sur une période de traitement de deux ans chez des femmes ménopausées d’âge inférieur ou égal à 60 ans hystérectomisées ou non. Les femmes avaient une ancienneté de ménopause située entre 2 et 8 ans. Trois essais cliniques ont inclus 1 764 femmes ménopausées traitées soit par du chlorhydrate de raloxifène en association avec du calcium soit par placebo et calcium. Dans l’un de ces essais, les femmes avaient subi une hystérectomie. Le chlorhydrate de raloxifène a entraîné des augmentations significatives de la densité minérale osseuse de la hanche et du rachis ainsi que de la masse osseuse du corps entier comparé au placebo. En général, cette augmentation de la DMO était de 2 % par rapport au placebo. Une augmentation similaire de la DMO a été observée dans la population incluse dans les essais de traitement ayant reçu jusqu’à 7 ans de traitement par chlorhydrate de raloxifène. Dans les essais de prévention, le pourcentage de patientes ayant présenté une augmentation ou une baisse de DMO sous chlorhydrate de raloxifène était au niveau du rachis, baisse pour 37 % des patientes et augmentation pour 63 %; et au niveau de la hanche totale, baisse pour 29 % des patientes et augmentation pour 71 %.</p>
<p class=AmmCorpsTexte>iii) Cinétique du calcium. Le chlorhydrate de raloxifène et les œstrogènes ont un effet similaire sur le remodelage osseux et sur le métabolisme calcique. Le chlorhydrate de raloxifène est associé à une réduction de la résorption osseuse et à un déplacement positif de la valeur moyenne de la balance calcique de 60 mg par jour, dû principalement à une diminution des pertes calciques urinaires.</p>
<p class=AmmCorpsTexte>iv) Histomorphométrie (qualité de l'os). Dans une étude comparant le chlorhydrate de raloxifène aux œstrogènes, l'os de patientes traitées par l'un ou l'autre produit était normal du point de vue histologique, sans mise en évidence de défaut de minéralisation, d'os d'aspect tissé ni de fibrose médullaire.</p>
<p class=AmmCorpsTexte>Le chlorhydrate de raloxifène diminue la résorption osseuse ; cet effet osseux se traduit par une réduction du niveau des marqueurs de remodelage osseux sériques et urinaires, par une réduction de la résorption osseuse observée dans des études de cinétiques de calcium radiomarqué, et par une augmentation de la DMO et une réduction de l’incidence des fractures.</p>
<p class=AmmCorpsTexteGras>b) Effets sur le métabolisme lipidique et sur le risque cardio-vasculaire</p>
<p class=AmmCorpsTexte>Les essais cliniques ont montré que le chlorhydrate de raloxifène à 60 mg par jour réduit significativement le cholestérol total (3 à 6 %), le LDL-cholestérol (4 à 10 %). Les femmes avec les taux initiaux de cholestérol les plus élevés ont montré les plus fortes réductions. Les concentrations de HDL-cholestérol et de triglycérides n'ont pas changé de manière significative. Après 3 ans de traitement le chlorhydrate de raloxifène a réduit le fibrinogène (6,71 %). Dans l’étude de traitement de l’ostéoporose (n=7705 patientes), un nombre significativement plus faible de patientes traitées par le chlorhydrate de raloxifène a eu besoin de débuter une thérapie hypolipémiante par comparaison au placebo.</p>
<p class=AmmCorpsTexte>Le traitement par le chlorhydrate de raloxifène pendant 8 ans n’a pas influencé significativement le risque d’accidents cardiovasculaires chez les patientes incluses dans l’essai de traitement de l’ostéoporose. De même, dans l’étude RUTH, comparé au placebo, le chlorhydrate de raloxifène n’a pas influencé l’incidence des infarctus du myocarde, des hospitalisations pour syndrome coronarien aigu, des accidents vasculaires cérébraux ou de la mortalité globale, y compris de la mortalité globale d’origine cardiovasculaire (pour l’augmentation du risque d’accident vasculaire cérébral fatal voir rubrique 4.4).</p>
<p class=AmmCorpsTexte>Le risque relatif d’accident veineux thrombo-embolique observé sous chlorhydrate de raloxifène était de 1,60 (IC : 0,95-2,71) par comparaison au placebo, et le risque relatif était de 1,0 (IC : 0,3-6,2) par comparaison aux œstrogènes ou au traitement hormonal substitutif (THS). Le risque d’accident thromboembolique était plus important au cours des quatre premiers mois de traitement.</p>
<p class=AmmCorpsTexteGras>c) Effets sur l'endomètre et le plancher pelvien</p>
<p class=AmmCorpsTexte>Dans les essais cliniques, le chlorhydrate de raloxifène n'a pas stimulé l'endomètre post-ménopausique. Par comparaison au placebo, le raloxifène n'a pas été associé à des spottings, des saignements ou des hyperplasies endométriales. Environ 3 000 échographies transvaginales (ETV) ont été évaluées chez 831 patientes, tous groupes confondus. L’épaisseur endométriale des patientes sous chlorhydrate de raloxifène n’était pas différente de celle des patientes sous placebo. Après 3 ans de traitement, une augmentation de l’épaisseur endométriale d’au moins 5 mm évaluée par échographie transvaginale, a été observée chez 1,9 % des 211 femmes traitées par chlorhydrate de raloxifène 60 mg/jour en comparaison aux 1,8 % des 219 femmes sous placebo. Il n’y a eu aucune différence entre le groupe chlorhydrate de raloxifène et le groupe placebo en ce qui concerne l’incidence des saignements d’origine utérine rapportés.</p>
<p class=AmmCorpsTexte>Les biopsies endométriales réalisées après 6 mois de traitement par chlorhydrate de raloxifène 60 mg/jour ont montré un endomètre de type non prolifératif chez toutes les patientes. De plus, dans un essai utilisant une posologie 2,5 fois supérieure à la posologie recommandée, il n’a pas été mis en évidence de prolifération endométriale ou d’augmentation du volume utérin.</p>
<p class=AmmCorpsTexte>Dans l’essai de traitement de l’ostéoporose, l’épaisseur endométriale a été évaluée tous les ans dans un sous-groupe de patientes (1644 patientes) pendant 4 ans. L’épaisseur endométriale chez les femmes traitées pendant 4 ans par chlorhydrate de raloxifène n’étaient pas différentes des valeurs initiales. Il n’y a pas eu de différence entre le chlorhydrate de raloxifène et le placebo en ce qui concerne l’incidence des saignements vaginaux (“ spottings ”) ou des pertes vaginales. Un nombre plus faible de patientes traitées par chlorhydrate de raloxifène par comparaison au placebo a eu recours à une intervention chirurgicale pour prolapsus utérin. Les données de tolérance après trois ans de traitement par chlorhydrate de raloxifène suggèrent que le traitement par le chlorhydrate de raloxifène n’augmente pas le relâchement du plancher pelvien et les interventions chirurgicales sur le plancher pelvien.</p>
<p class=AmmCorpsTexte>Après 4 ans, le chlorhydrate de raloxifène n’a pas augmenté le risque de cancer de l’endomètre ou des ovaires. Des polypes bénins de l’endomètre ont été rapportés chez 0,9 % des femmes ménopausées qui ont reçu du chlorhydrate de raloxifène pendant 4 ans, par comparaison à 0,3 % chez les femmes qui ont reçu le placebo.</p>
<p class=AmmCorpsTexteGras>d) Effets sur le tissu mammaire</p>
<p class=AmmCorpsTexte>Le chlorhydrate de raloxifène ne stimule pas le tissu mammaire. Dans tous les essais cliniques contrôlés versus placebo, la fréquence et la sévérité des symptômes mammaires étaient identiques dans les groupes de chlorhydrate de raloxifène et placebo (pas de gonflement, de tension ou de douleur mammaire).</p>
<p class=AmmCorpsTexte>Au cours des 4 années de l’essai de traitement de l’ostéoporose (n=7705 patientes), le traitement par le chlorhydrate de raloxifène comparé au placebo a réduit le risque de cancer du sein, tous types confondus, de 62 % (RR = 0,38 ; IC : 0,21-0,69), le risque de cancer du sein invasif de 71 % (RR = 0,29 ; IC : 0,13-0,58) et le risque de cancer du sein invasif à récepteurs œstrogéniques positifs (RE+) de 79% (RR = 0,21 ; IC : 0,07-0,50). Le chlorhydrate de raloxifène n’a pas d’effet sur le risque de cancer du sein à récepteurs œstrogéniques négatifs (RE-). Ces observations corroborent la conclusion selon laquelle le chlorhydrate de raloxifène n’a pas d’activité agoniste œstrogénique intrinsèque sur le tissu mammaire.</p>
<p class=AmmCorpsTexteGras>e) Effet sur les fonctions cognitives</p>
<p class=AmmCorpsTexte>Aucun effet indésirable sur les fonctions cognitives n’a été observé.</p>
<p class="AmmAnnexeTitre2"><a name="RcpPropPharmacocinetique">5.2. Propriétés pharmacocinétiques</a></p>
<p class=AmmAnnexeTitre3><a name="_Toc142278934"><span style='letter-spacing: -.05pt'>A</span>bso<span style='letter-spacing:.05pt'>r</span>p<span style='letter-spacing:.05pt'>ti</span>on</a></p>
<p class=AmmCorpsTexte>Le chlorhydrate de raloxifène<span style='letter-spacing: .05pt'> </span>est<span style='letter-spacing:.05pt'> r</span>ap<span style='letter-spacing:.05pt'>i</span>de<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>abso<span style='letter-spacing:.05pt'>r</span>bé<span style='letter-spacing:.05pt'> </span>ap<span style='letter-spacing:.05pt'>r</span>ès<span style='letter-spacing:.05pt'> </span>ad<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>on o<span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:.05pt'>l</span>e. En<span style='letter-spacing:-.1pt'>v</span><span style='letter-spacing:.05pt'>ir</span>on 60 %<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing: .05pt'>l</span>a<span style='letter-spacing:.05pt'> </span>dose<span style='letter-spacing:.05pt'> </span>ora<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> </span>est abso<span style='letter-spacing:.05pt'>r</span>bée. La<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>l</span>ucu<span style='letter-spacing:.05pt'>r</span>on<span style='letter-spacing:.05pt'>i</span>sa<span style='letter-spacing:.05pt'>ti</span>on p<span style='letter-spacing:.05pt'>r</span>és<span style='letter-spacing:-.1pt'>y</span>s<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>que<span style='letter-spacing:.05pt'> </span>est<span style='letter-spacing:.05pt'> i</span><span style='letter-spacing:-.2pt'>m</span>po<span style='letter-spacing:.05pt'>rt</span>an<span style='letter-spacing:.05pt'>t</span>e. La<span style='letter-spacing:.05pt'> </span>b<span style='letter-spacing:.05pt'>i</span>od<span style='letter-spacing:.05pt'>i</span>spon<span style='letter-spacing:.05pt'>i</span>b<span style='letter-spacing:.05pt'>ilit</span>é<span style='letter-spacing:.05pt'> </span>abso<span style='letter-spacing:.05pt'>l</span>ue<span style='letter-spacing:.05pt'> </span>du chlorhydrate de raloxifène est<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> </span>2 <span style='letter-spacing:.05pt'>%</span>.<span style='letter-spacing:.05pt'> </span></p>
<p class=AmmCorpsTexte><span style='letter-spacing:-.05pt'>L</span>e<span style='letter-spacing:.05pt'> t</span>e<span style='letter-spacing:-.2pt'>m</span>ps nécessa<span style='letter-spacing:.05pt'>ir</span>e<span style='letter-spacing: .05pt'> </span>pour a<span style='letter-spacing:.05pt'>tt</span>e<span style='letter-spacing:.05pt'>i</span>ndre<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>concen<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>on<span style='letter-spacing:.05pt'> </span>plas<span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>ti</span>que <span style='letter-spacing:-.2pt'>m</span>o<span style='letter-spacing:-.15pt'>y</span>enne <span style='letter-spacing:-.2pt'>m</span>ax<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> l</span>a b<span style='letter-spacing:.05pt'>i</span>od<span style='letter-spacing:.05pt'>i</span>spon<span style='letter-spacing:.05pt'>i</span>b<span style='letter-spacing:.05pt'>ilit</span>é<span style='letter-spacing:.05pt'> </span>sont<span style='letter-spacing:.05pt'> f</span>onc<span style='letter-spacing:.05pt'>ti</span>on de<span style='letter-spacing:.05pt'> l’i</span>n<span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing: .05pt'>r</span>con<span style='letter-spacing:-.1pt'>v</span>e<span style='letter-spacing:.05pt'>r</span>s<span style='letter-spacing:.05pt'>i</span>on s<span style='letter-spacing:-.1pt'>y</span>s<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>que<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> </span>du c<span style='letter-spacing:-.1pt'>y</span>c<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'>r</span>o<span style='letter-spacing:-.3pt'>-</span>hépa<span style='letter-spacing:.05pt'>ti</span>que<span style='letter-spacing:.05pt'> </span>du chlorhydrate de raloxifène et<span style='letter-spacing:.05pt'> </span>de ses<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>é<span style='letter-spacing:.05pt'>t</span>abol<span style='letter-spacing:.05pt'>it</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>l</span>ucurocon<span style='letter-spacing:.1pt'>j</span>u<span style='letter-spacing:-.15pt'>g</span>ués.</p>
<p class=AmmAnnexeTitre3><span style='letter-spacing:-.05pt'>D</span>istribu<span style='letter-spacing:-.05pt'>t</span>ion</p>
<p class=AmmCorpsTexte>Le chlorhydrate de raloxifène est<span style='letter-spacing: .05pt'> l</span>a<span style='letter-spacing:.05pt'>r</span><span style='letter-spacing:-.1pt'>g</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>tri</span>bué dans <span style='letter-spacing: .05pt'>l’</span>or<span style='letter-spacing:-.1pt'>g</span>an<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:-.2pt'>m</span>e.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>L</span>e<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>v</span>o<span style='letter-spacing:.05pt'>l</span>u<span style='letter-spacing:-.2pt'>m</span>e<span style='letter-spacing:.05pt'> </span>de d<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'>tri</span>but<span style='letter-spacing:.05pt'>i</span>on<span style='letter-spacing:.05pt'> </span>n<span style='letter-spacing:-.25pt'>'</span>est<span style='letter-spacing:.05pt'> </span>pas p<span style='letter-spacing:.05pt'>r</span>opo<span style='letter-spacing:.05pt'>rti</span>onnel<span style='letter-spacing:.05pt'> </span>à<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing: .05pt'> </span>dose. Le chlorhydrate de raloxifène est<span style='letter-spacing: .05pt'> f</span>o<span style='letter-spacing:.05pt'>rt</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> li</span>é<span style='letter-spacing:.05pt'> </span>aux p<span style='letter-spacing:.05pt'>r</span>o<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'>i</span>nes<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>l</span>as<span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>ti</span>ques<span style='letter-spacing:.05pt'> (</span>98<span style='letter-spacing:-.35pt'>-</span>99 <span style='letter-spacing:.05pt'>%).</span></p>
<p class=AmmAnnexeTitre3><span style='letter-spacing:-.05pt'>Métabolisme</span></p>
<p class=AmmCorpsTexte>Le chlorhydrate de raloxifène sub<span style='letter-spacing: .05pt'>i</span>t<span style='letter-spacing:.05pt'> </span>un <span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.2pt'>m</span>po<span style='letter-spacing:.05pt'>rt</span>ant<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>é<span style='letter-spacing:.05pt'>t</span>abo<span style='letter-spacing:.05pt'>li</span>s<span style='letter-spacing:-.2pt'>m</span>e<span style='letter-spacing:.05pt'> </span>en <span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:-.05pt'>é</span><span style='letter-spacing:.05pt'>t</span>abo<span style='letter-spacing:.05pt'>lit</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>l</span>ucu<span style='letter-spacing:.05pt'>r</span>ocon<span style='letter-spacing:.15pt'>j</span>u<span style='letter-spacing:-.1pt'>g</span>ués<span style='letter-spacing:.05pt'> l</span>o<span style='letter-spacing:.05pt'>r</span>s<span style='letter-spacing:.05pt'> </span>du p<span style='letter-spacing:.05pt'>r</span>e<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>er passa<span style='letter-spacing:-.1pt'>g</span>e:<span style='letter-spacing:.05pt'> r</span>a<span style='letter-spacing:.05pt'>l</span>oxi<span style='letter-spacing:.05pt'>f</span>èn<span style='letter-spacing:-.05pt'>e</span><span style='letter-spacing:-.2pt'>-</span>4<span style='letter-spacing:-.2pt'>'-</span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>l</span>ucu<span style='letter-spacing:.05pt'>r</span>on<span style='letter-spacing:.05pt'>i</span>de, <span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:.05pt'>l</span>ox<span style='letter-spacing:.05pt'>if</span>ène<span style='letter-spacing:-.2pt'>-</span>6<span style='letter-spacing:-.2pt'>-</span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>l</span>ucu<span style='letter-spacing:.05pt'>r</span>on<span style='letter-spacing:.05pt'>i</span>de<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> r</span>a<span style='letter-spacing:.05pt'>l</span>ox<span style='letter-spacing:.05pt'>if</span>ène<span style='letter-spacing:-.2pt'>-</span>6,4<span style='letter-spacing:.05pt'>’</span><span style='letter-spacing:-.2pt'>-</span>d<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>l</span>ucu<span style='letter-spacing:.05pt'>r</span>on<span style='letter-spacing:.05pt'>i</span>de. <span style='letter-spacing:-.05pt'>A</span>ucun au<span style='letter-spacing:.05pt'>tr</span>e<span style='letter-spacing: .05pt'> </span><span style='letter-spacing:-.2pt'>m</span>é<span style='letter-spacing:.05pt'>t</span>abol<span style='letter-spacing:.05pt'>it</span>e<span style='letter-spacing:.05pt'> </span>n<span style='letter-spacing:-.2pt'>'</span>a<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:-.1pt'>v</span><span style='letter-spacing:.05pt'>i</span>dence.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>L</span>e<span style='letter-spacing:.05pt'> </span>chlorhydrate de raloxifène co<span style='letter-spacing:-.2pt'>m</span>prend<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.25pt'>m</span>o<span style='letter-spacing:.05pt'>i</span>ns de 1<span style='letter-spacing:-.1pt'> </span>%<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing: .05pt'> </span>concen<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>ons co<span style='letter-spacing:-.2pt'>m</span>b<span style='letter-spacing:.05pt'>i</span>nées<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:.05pt'>l</span>ox<span style='letter-spacing:.05pt'>if</span>ène<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>é<span style='letter-spacing:.05pt'>t</span>abo<span style='letter-spacing:.05pt'>lit</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>l</span>ucu<span style='letter-spacing:.05pt'>r</span>ocon<span style='letter-spacing:.15pt'>j</span>u<span style='letter-spacing:-.1pt'>g</span>ués. Les<span style='letter-spacing:.05pt'> </span>concen<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>ons<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> </span>chlorhydrate de raloxifène sont <span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:.05pt'>t</span>enues<span style='letter-spacing:.05pt'> </span>par<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing:.05pt'> </span>c<span style='letter-spacing:-.1pt'>y</span>c<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'>r</span>ohépa<span style='letter-spacing:.05pt'>ti</span>que, donnant<span style='letter-spacing:.05pt'> </span>une<span style='letter-spacing: .05pt'> </span>de<span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:-.05pt'>i</span><span style='letter-spacing:-.2pt'>-</span><span style='letter-spacing:-.1pt'>v</span><span style='letter-spacing:.05pt'>i</span>e<span style='letter-spacing:.05pt'> </span>p<span style='letter-spacing:.05pt'>l</span>as<span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>ti</span>que<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> </span>27,7 heu<span style='letter-spacing:.05pt'>r</span>es.</p>
<p class=AmmCorpsTexte>Les<span style='letter-spacing:.05pt'> r</span>ésu<span style='letter-spacing:.05pt'>lt</span>a<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:.05pt'> i</span>ssus des<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>udes<span style='letter-spacing: .05pt'> </span>de dose<span style='letter-spacing:.05pt'> </span>ora<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> </span>unique du chlorhydrate de raloxifène préd<span style='letter-spacing:.05pt'>i</span>sent<span style='letter-spacing:.05pt'> l</span>e<span style='letter-spacing:.05pt'> </span>pro<span style='letter-spacing:.05pt'>fi</span>l<span style='letter-spacing:.05pt'> </span>pha<span style='letter-spacing:.05pt'>r</span><span style='letter-spacing:-.2pt'>m</span>acoc<span style='letter-spacing:.05pt'>i</span>né<span style='letter-spacing:.05pt'>ti</span>que des<span style='letter-spacing:.05pt'> </span>doses<span style='letter-spacing: .05pt'> </span><span style='letter-spacing:-.2pt'>m</span>u<span style='letter-spacing:.05pt'>lti</span>p<span style='letter-spacing:.05pt'>l</span>es. L<span style='letter-spacing:.05pt'>’</span>au<span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:.05pt'>ti</span>on des<span style='letter-spacing:.05pt'> </span>doses<span style='letter-spacing:.05pt'> </span>de chlorhydrate de raloxifène<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>î</span>ne<span style='letter-spacing:.05pt'> </span>une<span style='letter-spacing:.05pt'> </span>au<span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:-.2pt'>m</span>en<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:.05pt'>ti</span>on p<span style='letter-spacing:.05pt'>r</span>a<span style='letter-spacing:.05pt'>ti</span>que<span style='letter-spacing:-.2pt'>m</span>ent p<span style='letter-spacing:.05pt'>r</span>opo<span style='letter-spacing: .05pt'>rti</span>onne<span style='letter-spacing:.05pt'>ll</span>e<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> l’</span>a<span style='letter-spacing:.05pt'>ir</span>e<span style='letter-spacing:.05pt'> </span>sous<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>cou<span style='letter-spacing:.05pt'>r</span>be<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>concen<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>on p<span style='letter-spacing:.05pt'>l</span>as<span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>ti</span>que<span style='letter-spacing:.05pt'> </span>en <span style='letter-spacing:.05pt'>f</span>onc<span style='letter-spacing:.05pt'>ti</span>on du <span style='letter-spacing:.05pt'>t</span>e<span style='letter-spacing: -.2pt'>m</span>ps<span style='letter-spacing:.05pt'> (</span><span style='letter-spacing:-.05pt'>AUC</span><span style='letter-spacing:.05pt'>)</span>.</p>
<p class=AmmAnnexeTitre3>Excrétion</p>
<p class=AmmCorpsTexte>La<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.15pt'>j</span>o<span style='letter-spacing:.05pt'>rit</span>é<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:-.2pt'>'</span>une<span style='letter-spacing:.05pt'> </span>dose<span style='letter-spacing:.05pt'> </span>de chlorhydrate de raloxifène et<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>é<span style='letter-spacing:.05pt'>t</span>abol<span style='letter-spacing:.05pt'>it</span>es<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>l</span>ucurocon<span style='letter-spacing:.1pt'>j</span>u<span style='letter-spacing:-.15pt'>g</span>ués<span style='letter-spacing:.05pt'> </span>est<span style='letter-spacing:.05pt'> </span>exc<span style='letter-spacing:.05pt'>r</span>é<span style='letter-spacing:.05pt'>t</span>ée<span style='letter-spacing:.05pt'> </span>dans <span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> </span>5<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:.15pt'>j</span>ours et<span style='letter-spacing:.05pt'> </span>se<span style='letter-spacing:.05pt'> r</span>e<span style='letter-spacing: .05pt'>tr</span>ou<span style='letter-spacing:-.15pt'>v</span>e<span style='letter-spacing:.05pt'> </span>essen<span style='letter-spacing:.05pt'>ti</span>e<span style='letter-spacing:.05pt'>ll</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>dans <span style='letter-spacing:.05pt'>l</span>es<span style='letter-spacing:.05pt'> f</span>èces,<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>o<span style='letter-spacing:.05pt'>i</span>ns de 6<span style='letter-spacing:-.05pt'> </span>%<span style='letter-spacing: .05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>ant<span style='letter-spacing:.05pt'> </span>exc<span style='letter-spacing:.05pt'>r</span>é<span style='letter-spacing:.05pt'>t</span>és<span style='letter-spacing:.05pt'> </span>dans <span style='letter-spacing:.05pt'>l’</span>ur<span style='letter-spacing:.05pt'>i</span>ne.</p>
<p class=AmmAnnexeTitre3>Popu<span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'>ti</span>ons<span style='letter-spacing:.05pt'> </span>spéc<span style='letter-spacing:.05pt'>ifi</span>ques</p>
<p class=AmmCorpsTexte><span style='letter-spacing:-.2pt'>I</span>nsuf<span style='letter-spacing:.05pt'>fi</span>sance<span style='letter-spacing:.05pt'> r</span>éna<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing: .05pt'> </span>-<span style='letter-spacing:-.2pt'> </span>Mo<span style='letter-spacing:.05pt'>i</span>ns<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> </span>6 %<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span>dose<span style='letter-spacing:.05pt'> t</span>o<span style='letter-spacing: .05pt'>t</span>a<span style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:.05pt'> </span>est é<span style='letter-spacing:.05pt'>li</span><span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>née<span style='letter-spacing:.05pt'> </span>dans<span style='letter-spacing:.05pt'> l’</span>u<span style='letter-spacing:.05pt'>ri</span>ne. <span style='letter-spacing:-.05pt'>D</span>ans<span style='letter-spacing:.05pt'> </span>une<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>ude pha<span style='letter-spacing:.05pt'>r</span><span style='letter-spacing:-.2pt'>m</span>acoc<span style='letter-spacing:.05pt'>i</span>né<span style='letter-spacing:.05pt'>ti</span>que<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> </span>popu<span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'>ti</span>on, une<span style='letter-spacing:.05pt'> r</span>éduc<span style='letter-spacing:.05pt'>ti</span>on de<span style='letter-spacing:.05pt'> </span>47 %<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span>c<span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing: .05pt'>ir</span>ance<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span>c<span style='letter-spacing:.05pt'>r</span>éa<span style='letter-spacing:.05pt'>ti</span>n<span style='letter-spacing:.05pt'>i</span>ne a<span style='letter-spacing:.15pt'>j</span>us<span style='letter-spacing:.05pt'>t</span>ée<span style='letter-spacing:.05pt'> </span>pour <span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.2pt'>m</span>asse<span style='letter-spacing: .05pt'> </span><span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:.05pt'>r</span>e<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'> </span>en<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>î</span>né une d<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>nut<span style='letter-spacing:.05pt'>i</span>on<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:-.05pt'> </span>17<span style='letter-spacing:-.1pt'> </span>%<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> l</span>a<span style='letter-spacing:.05pt'> </span>c<span style='letter-spacing:.05pt'>l</span>a<span style='letter-spacing:.05pt'>ir</span>ance<span style='letter-spacing:.05pt'> </span>du chlorhydrate de raloxifène<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> </span>une<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.2pt'>m</span><span style='letter-spacing:.05pt'>i</span>nu<span style='letter-spacing:.05pt'>ti</span>on de 15 %<span style='letter-spacing:.05pt'> </span>de <span style='letter-spacing: .05pt'>l</span>a<span style='letter-spacing:.05pt'> </span>c<span style='letter-spacing:.05pt'>l</span>ai<span style='letter-spacing:.05pt'>r</span>ance<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> </span>dé<span style='letter-spacing:.05pt'>ri</span><span style='letter-spacing:-.1pt'>v</span>és<span style='letter-spacing:.05pt'> </span>con<span style='letter-spacing:.1pt'>j</span>u<span style='letter-spacing:-.15pt'>g</span>ués<span style='letter-spacing:.05pt'> </span>du<span style='letter-spacing:.05pt'> </span>chlorhydrate de raloxifène.</p>
<p class=AmmCorpsTexte><span style='letter-spacing:-.2pt'>I</span>nsuf<span style='letter-spacing:.05pt'>fi</span>sance<span style='letter-spacing:.05pt'> </span>hépa<span style='letter-spacing:.05pt'>ti</span>que -<span style='letter-spacing:-.2pt'> </span>La<span style='letter-spacing:.05pt'> </span>pha<span style='letter-spacing:.05pt'>r</span><span style='letter-spacing:-.2pt'>m</span>acoc<span style='letter-spacing:.05pt'>i</span>né<span style='letter-spacing:.05pt'>ti</span>que<span style='letter-spacing:.05pt'> </span>d<span style='letter-spacing:.05pt'>’</span>une<span style='letter-spacing:.05pt'> </span>dose<span style='letter-spacing:.05pt'> </span>un<span style='letter-spacing:.05pt'>i</span>que<span style='letter-spacing:.05pt'> </span>de<span style='letter-spacing:.05pt'> </span>chlorhydrate de raloxifène<span style='letter-spacing:.05pt'> </span>chez<span style='letter-spacing:-.1pt'> </span>des<span style='letter-spacing:.05pt'> </span>pa<span style='letter-spacing:.05pt'>ti</span>en<span style='letter-spacing:.05pt'>t</span>s a<span style='letter-spacing:-.1pt'>y</span>ant<span style='letter-spacing: .05pt'> </span>une c<span style='letter-spacing:.05pt'>irr</span>hose<span style='letter-spacing:.05pt'> </span>et<span style='letter-spacing:.05pt'> </span>une <span style='letter-spacing:.05pt'>i</span>nsuf<span style='letter-spacing: .05pt'>fi</span>sance<span style='letter-spacing:.05pt'> </span>hépa<span style='letter-spacing:.05pt'>ti</span>que <span style='letter-spacing:-.2pt'>m</span>odé<span style='letter-spacing:.05pt'>r</span>ée<span style='letter-spacing:.05pt'> (</span><span style='letter-spacing:-.05pt'>C</span>h<span style='letter-spacing:.05pt'>il</span><span style='letter-spacing:-.1pt'>d</span><span style='letter-spacing:-.2pt'>-</span>Pu<span style='letter-spacing:-.15pt'>g</span>h,<span style='letter-spacing:.05pt'> </span>c<span style='letter-spacing:.05pt'>l</span>asse<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>A</span>)<span style='letter-spacing:.05pt'> </span>a<span style='letter-spacing:.05pt'> </span>é<span style='letter-spacing:.05pt'>t</span>é<span style='letter-spacing:.05pt'> </span>co<span style='letter-spacing:-.2pt'>m</span>pa<span style='letter-spacing:.05pt'>r</span>ée<span style='letter-spacing:.05pt'> </span>à ce<span style='letter-spacing:.05pt'>ll</span>e<span style='letter-spacing: .05pt'> </span>de su<span style='letter-spacing:.15pt'>j</span>e<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:.05pt'> </span>sa<span style='letter-spacing:.05pt'>i</span>ns.<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>L</span>es<span style='letter-spacing:.05pt'> </span>concen<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>ons p<span style='letter-spacing:.05pt'>l</span>as<span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>ti</span>ques<span style='letter-spacing:.05pt'> </span>de chlorhydrate de raloxifène é<span style='letter-spacing:.05pt'>t</span>a<span style='letter-spacing:.05pt'>i</span>ent<span style='letter-spacing:.05pt'> </span>approxi<span style='letter-spacing:-.2pt'>m</span>a<span style='letter-spacing:.05pt'>ti</span><span style='letter-spacing:-.1pt'>v</span>e<span style='letter-spacing:-.2pt'>m</span>ent<span style='letter-spacing:.05pt'> </span>2,5 <span style='letter-spacing:.05pt'>f</span>o<span style='letter-spacing:.05pt'>i</span>s<span style='letter-spacing:.05pt'> </span>supé<span style='letter-spacing:.05pt'>ri</span>eures<span style='letter-spacing:.05pt'> </span>à<span style='letter-spacing:.05pt'> </span>ce<span style='letter-spacing:.05pt'>ll</span>es<span style='letter-spacing:.05pt'> </span>des<span style='letter-spacing:.05pt'> t</span>é<span style='letter-spacing:-.2pt'>m</span>o<span style='letter-spacing:.05pt'>i</span>ns et<span style='letter-spacing:.05pt'> </span>cor<span style='letter-spacing: .05pt'>r</span>é<span style='letter-spacing:.05pt'>l</span>ées<span style='letter-spacing:.05pt'> </span>aux<span style='letter-spacing:.05pt'> </span>concen<span style='letter-spacing:.05pt'>tr</span>a<span style='letter-spacing:.05pt'>ti</span>ons de b<span style='letter-spacing:.05pt'>ilir</span>ubine.</p>
<p class="AmmAnnexeTitre2"><a name="RcpSecuritePreclinique">5.3. Données de sécurité préclinique</a></p>
<p class=AmmCorpsTexte>Dans une étude de carcinogénicité de 2 ans chez le rat, une augmentation des tumeurs ovariennes ayant pour origine les cellules de la granulosa/thèque a été observée chez les femelles recevant des doses élevées (279 mg/kg/jour). La biodisponibilité du chlorhydrate de raloxifène (AUC) dans ce groupe était environ 400 fois celle des femmes ménopausées recevant une dose de 60 mg. Dans une étude de carcinogénicité de 21 mois chez la souris, on a observé une augmentation de l’incidence des tumeurs des cellules interstitielles des testicules, des adénomes prostatiques et des adénocarcinomes chez les mâles recevant 41 ou 210 mg/kg, et des leïomyoblastomes prostatiques chez les mâles recevant 210 mg/kg. Chez la souris femelle, il a été observé une augmentation de l’incidence des tumeurs ovariennes chez les animaux recevant 9 à 242 mg/kg (0,3 à 32 fois l’AUC chez l’homme), incluant des tumeurs bénignes ou malignes des cellules de la lignée granulosa/thèque et des tumeurs bénignes des cellules de la lignée épithéliale. Dans ces études les rongeurs femelles ont été traités durant leur période de reproduction, au moment où leurs ovaires étaient fonctionnels et répondaient fortement aux stimulations hormonales. Contrairement aux ovaires fortement répondeurs dans ce modèle de rongeur, dans l’espèce humaine, l’ovaire après la ménopause est très peu répondeur à la stimulation des hormones de la reproduction.</p>
<p class=AmmCorpsTexte>Les nombreux tests effectués n’ont pas montré d’effet génotoxique du chlorhydrate de raloxifène.</p>
<p class=AmmCorpsTexte>Les effets sur la reproduction et le développement observés chez les animaux sont conformes au profil pharmacologique connu du chlorhydrate de raloxifène. A des doses de 0,1 à 10 mg/kg/jour chez la rate, le chlorhydrate de raloxifène a interrompu les cycles oestraux des rates pendant le traitement, mais n'a pas retardé les accouplements fertiles après la fin du traitement et a réduit, mais de façon marginale seulement, la taille des portées, augmenté la durée de gestation et altéré la durée des séquences du développement néonatal. Lorsqu’il a été administré pendant la période de pré-implantation, le chlorhydrate de raloxifène a retardé et interrompu l'implantation de l'embryon, entraînant une gestation prolongée et une portée de taille réduite mais le développement de la naissance au sevrage n’a pas été affecté. Des études de tératogenèse ont été menées chez le lapin et le rat. </p>
<p class=AmmCorpsTexte>Chez le lapin, des avortements, des faibles taux de malformations septales ventriculaires (&#8805; 0,1 mg/kg) et des hydrocéphalies (&#8805; 10 mg/kg) ont été observés. Chez le rat, des retards de développement, des malformations costales et des excavations rénales (&#8805; 1 mg/kg) sont apparus.</p>
<p class=AmmCorpsTexte>Le chlorhydrate de raloxifène est un anti-œstrogène puissant de l'utérus de la rate et a empêché la croissance de tumeurs mammaires oestrogéno-dépendantes chez le rat et la souris.</p>
<p class="AmmAnnexeTitre1"><a name="RcpDonneesPharmaceutiques">6. DONNEES PHARMACEUTIQUES</a></p>
<p class="AmmAnnexeTitre2"><a name="RcpListeExcipients">6.1. Liste des excipients</a></p>
<p class=AmmCorpsTexte><a name="_Toc142278937"><u>Noyau du comprimé</u> : <span class=tableau2>Carboxyméthylamidon sodique,</span> Acide citrique monohydraté, Cellulose microcristalline<u>, </u>Phosphate de Calcium dibasique, Poloxamère 407, Stéarate de magnésium.</a></p>
<p class=AmmCorpsTexte><u>Pelliculage</u> : Opadry II OY-LS-28908 blanc [Hypromellose, Lactose monohydraté, Dioxyde de titane (E171), Macrogol/ PEG 4000].</p>
<p class="AmmAnnexeTitre2"><a name="RcpIncompatibilites">6.2. Incompatibilités</a></p>
<p class=AmmCorpsTexte>Sans objet.</p>
<p class="AmmAnnexeTitre2"><a name="RcpDureeConservation">6.3. Durée de conservation</a></p>
<p class=AmmCorpsTexte>3 ans</p>
<p class="AmmAnnexeTitre2"><a name="RcpPrecConservation">6.4. Précautions particulières de conservation</a></p>
<p class=AmmCorpsTexte>Conserver dans l’emballage d’origine à l’abri de la lumière et de l’humidité. Ne pas congeler.</p>
<p class="AmmAnnexeTitre2"><a name="RcpEmballage">6.5. Nature et contenu de l'emballage extérieur</a></p>
<p class=AmmCorpsTexte>14, 28, 30, 84 et 90 comprimés sous plaquettes (PVC/PE/PVDC/Aluminium).</p>
<p class=AmmCorpsTexte>Toutes les présentations peuvent ne pas être commercialisées.</p>
<p class="AmmAnnexeTitre2"><a name="RcpPrecEmpl">6.6. Précautions particulières d’élimination et de manipulation</a></p>
<p class=AmmCorpsTexte>Pas d'exigences particulières.</p>
<p class="AmmAnnexeTitre1"><a name="RcpTitulaireAmm">7. TITULAIRE DE L’AUTORISATION DE MISE SUR LE MARCHE</a></p>
<p class=AmmTitulaireNom>cristers</p>
<p class=AmmTitulaireAdresse>22 quai GALLIENI</p>
<p class=AmmTitulaireAdresse>92150 SURESNES</p>
<p class="AmmAnnexeTitre1"><a name="RcpPresentation">8. NUMERO(S) D’AUTORISATION DE MISE SUR LE MARCHE</a></p>
<p class=AmmListePuces1 style='margin-left:17.85pt;text-align:justify; text-indent:-17.85pt;page-break-after:avoid'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>         </span></span>274 969-9 ou 34009 274 969 9 8 : 14 comprimés sous plaquettes (PVC/PE/PVDC/Aluminium).</p>
<p class=AmmListePuces1 style='margin-left:17.85pt;text-align:justify; text-indent:-17.85pt;page-break-after:avoid'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>         </span></span>274 970-7 ou 34009 274 970 7 0 : 28 comprimés sous plaquettes (PVC/PE/PVDC/Aluminium).</p>
<p class=AmmListePuces1 style='margin-left:17.85pt;text-align:justify; text-indent:-17.85pt;page-break-after:avoid'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>         </span></span>274 971-3 ou 34009 274 971 3 1 : 30 comprimés sous plaquettes (PVC/PE/PVDC/Aluminium).</p>
<p class=AmmListePuces1 style='margin-left:17.85pt;text-align:justify; text-indent:-17.85pt;page-break-after:avoid'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>         </span></span>274 973-6 ou 34009 274 973 6 0 : 84 comprimés sous plaquettes (PVC/PE/PVDC/Aluminium).</p>
<p class=AmmListePuces1><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>         </span></span>274 974-2 ou 34009 274 974 2 1 : 90 comprimés sous plaquettes (PVC/PE/PVDC/Aluminium).</p>
<p class="AmmAnnexeTitre1"><a name="RcpPremiereAutorisation">9. DATE DE PREMIERE AUTORISATION/DE RENOUVELLEMENT DE L’AUTORISATION</a></p>
<p class=AmmCorpsTexte><a name="_Toc142278945">[à compléter par le titulaire]</a></p>
<p class="AmmAnnexeTitre1"><a name="RcpDateRevision">10. DATE DE MISE A JOUR DU TEXTE</a></p>
<p class=AmmCorpsTexte><a name="_Toc142278946">[à compléter par le titulaire]</a></p>
<p class="AmmAnnexeTitre1"><a name="RcpDosimetrie">11. DOSIMETRIE</a></p>
<p class=AmmCorpsTexte>Sans objet.</p>
<p class="AmmAnnexeTitre1"><a name="RcpInstPrepRadioph">12. INSTRUCTIONS POUR LA PREPARATION DES RADIOPHARMACEUTIQUES</a></p>
<p class=AmmCorpsTexte>Sans objet.</p>
<div style='border:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0cm 0cm 0cm'>
<p class="AmmAnnexeTitre"><a name="RcpCondPrescription">CONDITIONS DE PRESCRIPTION ET DE DELIVRANCE</a></p>
</div>
<p class=AmmCorpsTexte>Liste I.</p>
<b><span style='font-size:12.0pt;font-family:Arial;color:#0B3D92;text-transform:
uppercase'><br clear=all>
</span></b>
</BODY>
</HTML>
